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ABSTRACT
Effectiveness of Acceptance and Commitment Therapy as a Treatment for
Posttraumatic Stress Disorder and Moral Injury
by
Ellen J. Bluett, Doctor of Philosophy
Utah State University, 2017
Major Professor: Michael P. Twohig, Ph.D.
Department: Psychology
Posttraumatic stress disorder (PTSD) is a common condition among military
personal and veterans. Despite strong empirical support for first line treatments for
PTSD, many veterans do not complete or respond to treatment. Research suggests that
experiential avoidance is a contributing factor to both treatment dropout and minimal
treatment gains. Acceptance and commitment therapy (ACT) is an empirically supported
cognitive behavioral intervention that aims to decrease experiential avoidance while
increasing psychological flexibility. Research has shown ACT to be a promising
intervention for the treatment of PTSD; however, its effectiveness in veterans with PTSD
is limited. Implementing an 8-week closed group design, this study examined the
effectiveness of an ACT intervention for veterans with PTSD and subclinical PTSD who
had previously completed a first line intervention for PTSD. Thirty-three veterans
enrolled in the intervention, which focused on vitality (e.g., increasing valued living and
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decreasing experiential avoidance) rather than symptom reduction. Symptom and process
of change measures including PTSD symptoms, valued living, and quality of life were
measured at pretreatment, posttreatment, and again at 1-month follow-up. Results found
that 64.7% of veterans showed a favorable response to treatment as measured by a 5point change in PTSD symptoms. Additionally, outcomes of interest including PTSD
symptoms, valued living, depression, wellbeing, and moral injury by transgressions
improved from pretreatment to posttreatment. Of note, a majority of treatment gains were
not maintained at follow-up. Overall, results provide preliminary support for ACT as a
second-line intervention for veteran PTSD. Empirical and clinical implications are
discussed along with the potential limitations and future directions of this study.
(161 pages)
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PUBLIC ABSTRACT
Effectiveness of Acceptance and Commitment Therapy as a Treatment for
Posttraumatic Stress Disorder and Moral Injury
Ellen J. Bluett
Posttraumatic stress disorder (PTSD) is a common condition among military
personal and veterans. Despite strong empirical support for first line treatments for
PTSD, many veterans do not complete or respond to treatment. Research suggests that
experiential avoidance is a contributing factor to both treatment dropout and minimal
treatment gains. Acceptance and commitment therapy (ACT) is an empirically supported
cognitive behavioral intervention that aims to decrease experiential avoidance while
increasing psychological flexibility. Research has shown ACT to be a promising
intervention for the treatment of PTSD; however, its effectiveness in veterans with PTSD
is limited.
In conjunction with Utah State University (USU) and the Salt Lake City Veterans
Affairs Medical Center, Ellen Bluett, a USU doctoral psychology student and staff
psychologist at the VA conducted a study to examine a next-step treatment for veterans
with PTSD. The main purpose of this study was to examine the effectiveness of an 8week closed group design ACT intervention for veterans with PTSD and subclinical
PTSD who had previously completed a first line intervention for PTSD. Thirty-three
veterans enrolled in the intervention, which focused on vitality (e.g., increasing valued
living and decreasing experiential avoidance) rather than symptom reduction. Symptom
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and process of change measures including PTSD symptoms, valued living, and quality of
life were measured at pretreatment, posttreatment, and again at 1-month follow-up.
Findings from this study showed that 64.7% of veterans showed a favorable
response to treatment as measured by a 5-point change in PTSD symptoms. Additionally,
outcomes of interest including PTSD symptoms, valued living, depression, wellbeing,
and moral injury by transgressions improved from pretreatment to posttreatment. Of note,
a majority of treatment gains were not maintained at follow-up. Overall, results provide
preliminary support for ACT as a second-line intervention for veteran PTSD.
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CHAPTER I
INTRODUCTION
Posttraumatic Stress Disorder (PTSD) is classified as a trauma and stressor related
disorder that is associated with severe stress reactions from exposure to a traumatic event
(American Psychiatric Association [APA], 2013). An estimated 50% of women and 60%
of men in the U.S. are exposed to a traumatic event during their lifetimes (Kessler,
Sonnega, Bromet, Hughes, & Nelson, 1995). Lifetime prevalence for PTSD rates range
from 7.8 to 25% (Green & Kaltman, 2003; Hidalgo & Davidson, 2000; Kessler et al.,
1995). According to Gates and colleagues the occurrence of PTSD is higher amongst
active military personal and veterans than the civilian population (Gates et al., 2012).
Furthermore, PTSD has been identified as a “signature injury” amongst service members
returning from deployments to Afghanistan to serve in OEF (Operation Enduring
Freedom) and deployments to Iraq to serve in OIF (Operation Iraqi Freedom; Gates et al.,
2012).
Military related trauma has other notable effects, including the potential to
damage or transgress an individual’s moral or ethical codes. Therefore, unsurprisingly
exposure to war can be instrumental in the development of moral injury (Farnsworth,
Drescher, Nieuwsma, Walser & Currier, 2014; Litz et al., 2009). Morally injurious
experiences include “perpetrating, failing to prevent, bearing witness to, or learning about
acts that transgress deeply held moral beliefs and expectations” (Litz et al., 2009, p. 697).
While, the etiology of moral injury shares similarities to fear conditioning and cognitive
models of PTSD, they are not one and the same (Nash & Litz, 2013). There is a growing
body of research aiming to understand how moral injury relates to posttraumatic stress
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(Farnsworth et al., 2014). Furthermore, no evidence-based treatments have been
developed for moral injury.
Importantly, while effective treatments exist for PTSD- such as prolonged
exposure and cognitive processing therapy, they are not without limitations. In fact, many
individuals do not respond, demonstrate minimal gains posttreatment, and do not
complete treatment (Garcia, Kelley, Rentz, & Lee, 2011; Steenkamp, Litz, Hoge, &
Marmar, 2015). Furthermore, dropout rates among the gold-standard treatments range
between 0 and 54% (Schottenbauer, Glass, Arnkoff, Tendick, & Gray, 2008). Some
literature suggests that avoidance may be the underlying factor contributing to treatment
dropout and poor treatment gains (Walser & Westrup, 2007). Recently, there has been
considerable research examining the role of experiential avoidance in the development
and maintenance of PTSD (Walser & Westrup, 2007). Experiential avoidance is a method
of actively avoiding or escaping particular private experiences, which is inversely related
to overall psychological functioning. Additionally, higher rates of experiential avoidance
correlate with poorer psychological functioning (e.g., Hayes, 2004; Walser & Westrup,
2007). Furthermore, experiential avoidance often reduces an individual’s ability to
engage in meaningful, values driven behaviors. In sum, research on alternative or
secondary treatment options for PTSD- that target experiential avoidance is warranted.
Acceptance-based interventions target experiential avoidance and promote
willingness to experience thoughts, feelings, and/or emotions, without changing their
form, meaning, or frequency. Ultimately, acceptance allows an individual to engage in
life regardless of the severity of their internal experiences. One such therapy, acceptance
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and commitment therapy (ACT) has growing support as an intervention for anxiety
disorders (Arch et al., 2012; Bluett, Homan, Morrison, Levin, & Twohig, 2014; Ruiz,
2010). The primary focus of an ACT treatment model is to increase behaviors that are
consistent with personal values while simultaneously allowing for any given internal
experience to be present. The emphasis on treatment is to increase vitality, rather than to
reduce symptoms. Furthermore, several small studies have provided preliminary support
for the use of ACT for PTSD.
Taken together, the prevalence and chronicity of PTSD and moral injury amongst
military personal, along with the limitations of existing treatments, warrants the
investigation of alternative treatment options for veterans with PTSD. Given the marked
avoidance and broken or betrayed sense of self often experienced by veterans with PTSD,
suggests that ACT may be useful at treating trauma associated with moral injury events.
Additionally, empirical support exists for group-based interventions for PTSD (Sloan,
Feinstein, Gallagher, Beck, & Keane, 2013). The purpose of this study is to examine the
effectiveness of an ACT group intervention for PTSD in veterans.
This study sought to answer the following research questions.
1. Is ACT an effective treatment for veterans with PTSD? Specifically, does
ACT positively impact PTSD symptom severity, quality of life, valued living,
depression, shame, and moral injury?
2. Do pretreatment levels of depression, moral injury, shame, psychological
inflexibility, and cognitive fusion predict response to treatment?
3. Do changes in psychological flexibility (AAQ-II) and valued living (VQ)
predict PTSD symptom severity posttreatment?
4. Is a group-based ACT intervention an acceptable treatment for veterans
diagnosed with PTSD?
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CHAPTER II
REVIEW OF THE LITERATURE

Posttraumatic Stress Disorder
PTSD is classified as a trauma and stressor related disorder that is associated with
severe stress reactions from exposure to a traumatic event. According to the DSM-5
(APA, 2013) a criterion “A” traumatic event is characterized as an event that threatens or
causes death, serious injury, or sexual violence to self or others. Traumatic events include
but are not limited to combat, natural disasters, motor-vehicle accidents, sexual assaults,
physical assaults, and sudden death of a loved one. Of note, the DSM-5 states that one or
more traumatic events (e.g., combat exposure) may be included in the diagnosis of PTSD
(APA, 2013). Four symptoms clusters characterize PTSD: re-experiencing or intrusion
(e.g., trauma related memories, flashbacks), avoidance of trauma-related internal or
external stimuli, alterations in arousal and reactivity (e.g., sleep disturbance, easily
startled), and negative changes in mood and cognitions following the traumatic event
(APA, 2013). In order to meet criteria for PTSD, symptoms must persist for at least a
month after the traumatic event, create significant dysfunction, and cannot be attributable
to substance use or another medical condition.

Prevalence
An estimated 50% of women and 60% of men in the U.S. are exposed to a
traumatic event during their lifetime (Kessler et al., 1995). Despite the frequency of
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trauma exposure, only a subset of the population develops PTSD (APA, 2000). Lifetime
prevalence rates for PTSD range from 7.8 to 25% (Green & Kaltman, 2003; Hidalgo &
Davidson, 2000; Kessler et al., 1995). A recent study examined PTSD prevalence rates
utilizing the DSM-5 criteria. Overall, prevalence rates for PTSD were slightly lower
using the DSM-5 criteria compared to the DSM-IV criteria. Unique to this study,
individuals with composite event PTSD, or PTSD symptomology attributable to a
combination of traumatic events versus PTSD criteria attributable to a single event per se,
were included. Of the 2,953 participating in the study, 89.7% reported experiencing one
or more criterion “A” traumas, with the average frequency of trauma exposure being
three events. Prevalence rates for individuals with composite event PTSD were as
follows: 9.4% lifetime, 5.3% in the past 12 months, and 4.2% in 6 months. For
individuals with same event PTSD, that is, all symptom criteria matching to the same
reported traumatic event, prevalence rates were 8.3% for lifetime, 4.7% in the past 12
months, and 3.8% in the past 6 months (Kilpatrick et al., 2013). In sum, regardless of
DSM edition, epidemiology research suggests that the frequency of PTSD is a substantial
and growing problem.
According to Gates and colleagues the occurrence of PTSD is higher amongst
active military personal and veterans than the civilian population (Gates et al., 2012)
PTSD has been identified as a “signature injury” amongst service members returning
from deployments to Afghanistan to serve in OEF and Iraq for OIF (Gates et al., 2012).
PTSD prevalence rates for recently deployed U.S. military personnel are as high as 14 to
16% (Gates et al., 2012; Tanielian & Jaycox, 2008). A report conducted by the
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Department of Veteran Affairs in June, 2009, suggested that nearly 25% of OEF/OIF
veterans receiving care at a VA were diagnosed with possible PTSD (Karlin et al., 2010).
This percentage approximates to nearly 120,000 veterans, indicating the urgency and
demand for providing evidence-based treatments for PTSD to U.S. veterans. These
findings are supported by a recent study reporting a 13.5 % weighted prevalence rate of
PTSD among more than 20,000 veterans serving between October 2001 and June 2008.
In this study, prevalence rates were higher for veterans who were deployed (15.7%) than
those who were not deployed (10.9%; Dursa, Reinhard, Barth & Schneiderman, 2014).
Additionally, a longitudinal study found that 11% of Vietnam veterans continue to
struggle with PTSD (Marmar, Schlenger, Henn-Hasse, 2015).
Moreover, a large body of evidence suggests that PTSD has detrimental effects on
the lives of active U.S. military personnel, veterans, and their families. Various negative
outcomes include increased anger and hostility (Jakupcak et al., 2007), occupational
insecurities and legal trouble (Solomon & Davidson, 1997), physical health problems
(Breslau & Davis, 1992; Schnurr & Green, 2004), as well as interpersonal problems
(Taft, Watkins, Stafford, Street, & Monson, 2011). In addition, studies have shown that
depression and anxiety (Rauch et al., 2010) and suicidal ideation (Jakupcak et al., 2009)
are more likely amongst veterans diagnosed with PTSD compared to veterans without
PTSD. Furthermore, one study reported that over 400,000 veterans received
compensation for PTSD (U.S. Department of Veterans Affairs, 2011). Overall, the
psychosocial impact of PTSD is marked and demands further attention. Military related
trauma has other notable effects, including moral transgression.

7
Moral Injury
The construct of moral injury has recently gained attention as a psychological
wound resulting from military service (Farnsworth et al., 2014). Moral injury has been
defined two ways. The founder of the term, Jonathon Shay, defines moral injury as a
psychological consequence resulting from a betrayal of what is considered right or moral
in a “high stakes” situation by an individual in a position of authority (Shay, 2014).
Alternatively, Litz et al. (2009) defined moral injury as a psychological state resulting
from an event in which an act or transgression occurs that opposes an individual’s
expectations about how one should behave (Litz et al., 2009). Both definitions include a
violation of one’s moral or ethical codes, however, a disparity exists in who is the
violator. Shay considers the person of power the violator while Litz et al. perceive the
violator to be the individual or the “self” (Litz et al., 2009; Shay, 2014). A further
distinction is that Shay purported that physiological arousal was a component of moral
injury. Regardless of the model applied, moral injury occurs when one’s moral
expectations are violated and/or invalidated by an event (Nash & Litz, 2013). Moral
injury appears to be a novel construct that extends beyond the DSM-5 criteria of PTSD.
Specifically, research suggests that moral challenges faced in a war may be an alternative
category of traumatic events, which is not captured in the current diagnostic criteria
(Currier et al., 2015). Moreover, the events that contribute to moral injury are customary
to modern day war.
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Morally Injurious Events
War can be instrumental in the development of moral injury (Currier,
McCormick, & Drescher, 2015; Litz et al., 2009). Morally injurious experiences include
“perpetrating, failing to prevent, bearing witness to, or learning about acts that transgress
deeply held moral beliefs and expectations” (Litz et al., 2009, p.700). At the root of moral
injury is the violation of morals, “fundamental assumptions about how things should
work and how one should behave in the world” (Litz, et al., p. 699). Litz et al. proposed
that the nature of wars in Iraq and Afghanistan are “unconventional,” including guerilla
warfare in an urban environment highlighted by civilian threats, IEDs (improvised
explosive devises), unmarked enemies, as well as increased danger for civilians and noncombat troops (Litz et al., 2009). Therefore, the unpredictable nature of modern day war
presents veterans with an increasing number of scenarios in which they are forced to
battle and possibly transgress their personal moral codes. Such moral conflicts include
killing an insurgent appearing as a civilian, witnessing dead bodies, and failing to assist
injured women and children (Litz et al., 2009). Ultimately, exposure to moral conflict
increases the likelihood of moral violation, resulting in emotions of shame, guilt, failure
for self-forgiveness, social problems, struggles with spirituality, and self-ridicule
(Drescher et al., 2011). Also, trust becomes a fundamental problem for individuals
inflicted with moral injury (Shay, 2014). Importantly, these peritraumatic and
posttraumatic emotions have been associated with both combat related moral injury and
military related PTSD (Farnsworth et al.,).
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Distinction from PTSD
PTSD is considered one of the “diagnostic correlates” of moral injury
(Farnsworth et al., 2014, p. 256). However, moral injury is not covered within the DSM-5
diagnostic criteria. To date, the literature distinguishes moral injury from PTSD in that
the event related to moral injury does not need to be perceived as life threatening. A
recent qualitative study aimed to evaluate and further define the construct of moral injury
outside of PTSD. In this study, 23 mental-health workers, chaplains, and researchers were
interviewed on their perception of an initial definition of moral injury and related
components. Overall, results showed that participants agreed that specific morally
injurious events occur that result in many psychological, spiritual, and behavioral
problems. Unanimously, the interviewees agreed that the construct of moral injury is both
necessary and affiliated with the diagnosis of PTSD but is not fully captured in the
diagnostic criteria (Drescher et al., 2011). In conclusion, this study indicated the
importance of moral injury as a construct and suggested that further measures of moral
injury be developed.
The growing literature on moral injury suggests that there are similarities in the
development of PTSD and moral injury (Farnsworth et al., 2014). Although moral injury
may be a distinct construct, various models of PTSD may contribute to the understanding
of moral injury. For example, social cognitive theories of PTSD purport that one’s basic
assumptions and beliefs about the world and self are violated as a result of a traumatic
experience. Within this model, failure to reconcile the event within one’s personal beliefs
may create guilt, shame, and distorted views of the self and world, all of which are
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associated with moral injury (Litz et al., 2009). Moreover, a qualitative analysis of 14
veterans from Iraq and Afghanistan, examined why moral injury may have occurred
during deployment. Veterans in the study were more likely to attribute psychological
factors (e.g., increased hopelessness, rage) to the development of moral injury. As a
result, veterans appeared to have increased self-blame and self-deprecation that may have
influenced their development and subsequent recovery from PTSD (Currier, McCormick,
& Drescher, 2015). Of note, the DSM-5 has now incorporated negative mood and
emotional states in the conceptualization and diagnoses of PTSD. Taken together,
research suggests that moral injury and PTSD share many similar cognitive and
emotional underpinnings, however, further research is needed.

Interventions for Moral Injury
Presently, no evidence-based treatments exist for moral injury. The etiology of
moral injury shares similarities to fear conditioning and cognitive models of PTSD but
are not one and the same (Nash & Litz, 2013). The majority of evidence-based treatment
models for PTSD are understood through a fear-conditioning paradigm, which may not
be the origin of moral injury (Drescher et al., 2011). Litz et al. (2009) highlighted the
need for alternative but complementary models for understanding moral injury and
traumatic stress. To date there is only one existing model for the treatment of moral
injury. Litz et al. presented an eight-step model integrating components from existing
PTSD treatment models including (a) emotional processing of memories related to the
morally injurious event and (b) exposure to corrective life experiences. The model
assumes that at the core of one’s moral injury is a deeply held belief that their actions are
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unforgivable and guilt and shame are deserved. Therefore, exposure to memories related
to the morally injurious event allows for a corrective emotional experience. Currently,
this intervention model is being tested as a “modified CBT;” however, no outcomes or
conclusions have been published at this time (Litz et al., 2009).
Intense guilt, shame, and anger are central components of moral injury, and
avoidance of such emotions contribute to the maintenance of it (Nash & Litz, 2013). In
addition, moral injury and avoidant behavior persist due to one’s inability to provide selfforgiveness for breaking one’s moral expectations. Furthermore, moral injury may result
in self-condemnation. Self-condemnation is the criticism or condemnation of the self as a
result of engagement in moral wrong doing or violation of one’s moral standards
(Drescher et al., 2011; Worthington & Langberg, 2012). Taken together, shame, selfcondemnation, and an inability to forgive are contributing factors to avoidant behavior
associated with moral injury. Thus, targeting avoidance of unwanted internal experiences
may be a viable treatment approach to target posttraumatic stress associated with moral
injury.

Evidence-Based Practices for PTSD
A substantial number of evidenced-based treatments exist for PTSD. Exposurebased behavioral therapies are often considered the gold standard treatment for anxiety
disorders, including PTSD (Norton & Price, 2007; Olatunji, Cisler, & Deacon, 2010).
Broadly, treatments under the larger umbrella of Cognitive Behavior Therapy (CBT),
including treatments possessing exposure components, have the most empirical support
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for the treatment of PTSD (Foa, Gillihan, & Bryant, 2013). According to Foa et al., most
cognitive behavioral therapies share two specific aims: (1) to encourage patients to
confront “safe” trauma reminders, and (2) to disconfirm dysfunctional beliefs that have
resulted from trauma exposure (Foa et al., 2013). One review indicated that Trauma
Focused-CBT, which includes components of psycho-education, exposure, and cognitive
restructuring, has strong support as an effective treatment for PTSD across trauma groups
(e.g., combat veterans, road traffic accident survivors, refugees, sexual assault victims,
and terrorism; Harvey, Bryant, & Tarrier, 2003). A notable amount of research supports
other evidence-based interventions, including prolonged exposure therapy, cognitive
processing therapy, eye-movement desensitization, and group therapy (Ehlers et al.,
2010; Ehlers & Clark, 2000).
Prolonged Exposure Therapy (PE) is an exposure-based therapy that consists of
two primary components- in vivo and imaginal exposure. In vivo exposure requires an
individual to systematically approach real-life scenarios that they have deemed unsafe.
Imaginal exposure requires an individual to revisit the traumatic memory through
systematically narrating the traumatic event (Foa & Rothbaum, 2001; Foa et al., 2013). A
significant amount of research exists supporting the efficacy of prolonged exposure
therapy for the treatment of PTSD (e.g., Foa et al., 2005; Foa, Rothbaum, & Furr, 2003;
Hagenaars, van Minnen, & Hoogduin, 2010; Powers, Halpern, Ferenschak, Gillihan, &
Foa, 2010). Of note, PE has been found effective in treating veterans who served in the
OEF/OIF conflicts (Rauch et al., 2010). Cognitive processing therapy (CPT) is a
therapeutic model that incorporates cognitive restructuring as well as exposure
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components with the intent of altering cognitive schemas that may be associated with
exposure to traumatic experience, including safety, trust, power, esteem, and intimacy
(Resick & Schnicke, 1992). Research has shown substantial support for CPT as an
efficacious treatment for PTSD (e.g., Resick, Nishith, Weaver, Astin, & Feuer, 2002).
Additionally, PE, along with CPT, have been “rolled out” as primary interventions for
PTSD, throughout Veterans Affairs health centers across the country (Garcia et al.,
2011). Eye movement desensitization and reprocessing (EMDR) requires an individual to
perform a series of saccadic eye movements while simultaneously imagining the trauma
memory and challenging their negative meaning(s) (Shapiro, 1996). Empirical support
exists for EMDR as an effective treatment for PTSD, however, it is not superior to
exposure-based treatments and the necessity of eye-movements remains controversial
(e.g., Davidson & Parker, 2001; Rothbaum, Astin, & Marsteller, 2005).
Group treatment is a common evidenced-based approach for the treatment of
PTSD in health care settings (Foy et al. 2010). A recent meta-analysis examined the
efficacy of group-based treatments for PTSD. A total of 16 studies with 1,686 individuals
were treated for PTSD within group settings. Results showed that group treatment was
efficacious within treatment conditions (d = 0.71), and greater effects were seen for those
in groups compared to waitlist-control conditions (d = 0.56). However, results showed
that effect sizes were nonsignificant for group treatment compared to other active
conditions (d = 0.09). In conclusion, while group treatment is an effective intervention, it
is not more effective than individual treatment (Sloan et al., 2013).
Several meta-analyses have assessed the strength of these aforementioned
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interventions. Overall, meta-analyses have found similar effects sizes across
psychotherapies for PTSD when compared to no-treatment controls or a
waitlist/supportive control group (e.g., J. Bisson & Andrew, 2005; J. I. Bisson et al.,
2007; Bradley, Greene, Russ, Dutra, & Westen, 2005; Van Etten & Taylor, 1998).
Alternatively, to control for treatment variables (e.g., treatment length, outcome
measures, disorder severity) recent studies have utilized direct-comparison methods
(Benish, Imel, & Wampold, 2008). One meta-analysis using a direct-comparison method
found no significant difference between EMDR and exposure-based treatments
(Davidson & Parker, 2001). Another meta-analysis aimed to provide an overall effect size
for “bona-fide” treatments of PTSD treatments. Bona-fide treatments are defined as
treatments that are “meant to be therapeutic” as determined by criteria from Wampold et
al. (1997). To be classified as bona-fide a treatment had to be delivered by a trained
therapist, tailored to the individual being treated, and meet two of the four criteria: a)
provide a reference to an established treatment (e.g., PE) (b) provide a description of the
therapy and the theory it was derived from (c) provide a treatment manual or (d) provide
a list of the active treatment components. Therefore, studies with supportive therapies,
component, and dismantling approaches were excluded. Fifteen studies were included in
the meta-analysis and met the following criteria: (a) two or more psychotherapy
comparisons, (b) no classification of treatments into categories, and (c) only included
bona-fide treatments (e.g., beyond supportive counseling). Benish et al. found that
between-group effect sizes for both PTSD and outcome measures were uniformly
distributed around zero. As such, the meta-analysis concluded that “bona fide” treatments
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for PTSD are equally efficacious (Benish et al., 2008). A critique by Ehlers et al. (2010)
dispute these findings, suggesting that the meta-analysis introduced bias in their head-tohead comparisons and failed to signify that treatments are more effective than the natural
recovery process. Furthermore, Ehlers et al. argued that over two decades of research
suggests that trauma focused cognitive behavioral therapies are the most efficacious
treatment for PTSD.

Limitation of Current Treatments
Importantly, while effective treatments exist for PTSD, such as PE and CPT, a
percentage of individuals do not respond to these treatments. Dropout rates for CBT vary
widely, with a range from 0 to 54% (Schottenbauer et al., 2008). A recent review
examined dropout rates across eight psychotherapy approaches for PTSD. Results
showed that dropout rates were highest for individuals treated with “full” CBT (28.5%)
compared to exposure (23.2%), CPT (23.2%) and integrative therapies, including
relaxation and supportive therapy (8.8%; Swift & Greenberg, 2014). In contrast, another
meta-analysis compared dropout rates amongst 42 clinical trials for PTSD, including 17
direct-comparisons. Across all studies, the average dropout rate was 18%. Interestingly,
within study comparison failed to show a difference in dropout rates amongst traumafocused therapies. However, trauma-focused therapies resulted in higher dropout rates
than present-centered therapy (Imel, Laska, Jakupcak, & Simpson, 2013). A study at a
specialized VA PTSD clinic examined dropout rates amongst 117 veterans receiving
variants of CBT (i.e., individual CPT or PE, group CPT, or individual or group CPT +
PE). Treatment dropout was defined as a veteran discontinuing treatment before they had
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reached a predetermined treatment goal (e.g., not having PTSD). Of the 117 veterans, 79
(67.5%) were considered dropouts. Age was a significant predictor in dropout, with
younger veterans less likely to complete treatment (Garcia et al., 2011). As Garcia et al.
wrote, “Our most effective treatments are only as good as the patient’s ability to complete
them” (p.1). In conclusion, notably high dropout rates suggest that further research on
other viable treatment options is warranted at this time.

Emerging Treatments for PTSD
Additional treatment options for PTSD continue to emerge. A recent study offers
a comprehensive review regarding the efficacy of alternative therapies for PTSD.
Overall, the review concludes that technology-based interventions, including virtual
reality exposure and internet-based treatments, have promising data (Cukor, Spitalnick,
Difede, Rizzo, & Rothbaum, 2009; Schottenbauer et al., 2008). Emerging
pharmacotherapies aimed at enhancing exposure therapy such as D-cycloserine have
limited but favorable data for enhancing extinction learning (Davis, Ressler, Rothbaum,
& Richardson, 2006). Imagery-based therapies including imagery rescripting was shown
to be effective in augmenting exposure (Arntz, Tiesema, & Kindt, 2007) while imagery
rehearsal therapy was shown to be effective in treating nightmares amongst veterans (Lu,
Wagner, Van Male, Whitehead, & Boehnlein, 2009). Notably, a new focus has been
placed on social and family based therapies such as Cognitive behavioral conjoint therapy
(Monson, Schnurr, Stevens & Guthrie, 2004) and Family systems therapy for trauma
(Ford et al., 1998). While research is scant in this area, inclusion of family members in
the treatment process has a strong theoretical support and warrants future investigation
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(Cukor et al., 2009). A recent meta-analysis examined the efficacy of writing therapy,
often referred to as narrative therapy, for the treatment of PTSD. Results showed writing
therapy to be an efficacious method of treatment compared to a waitlist control for PTS
and comorbid depression, however when compared to trauma-focused cognitive
behavioral therapy there was no significant difference. However, findings included in this
meta-analysis are limited considering that only six studies were included in the analysis
(van Emmerik, Reijntjes, & Kamphuis, 2012). Several other studies have examined the
function of behavioral approaches in the treatment of PTSD. Together, research suggests
that certain behavioral components such as behavioral activation (Jakupcak et al., 2009)
and introceptive exposure (Wald & Taylor, 2007) are successful additives to therapy but
should not be utilized as standalone treatments. In conclusion, several emerging
treatments exist for PTSD, however further research is needed on both the basic
processes of change as well as the effectiveness of these interventions (Shay, 2014).

Exposure Therapy and Modern CBT

Basic Science Support
Many anxiety treatments including exposure therapy originated through support
from basic science (e.g., Bouton, Mineka, & Barlow, 2001). Basic science suggests that
exposure therapy is purported to work through fear extinction. This process can be
understood as a translation of Pavlovian fear conditioning processes-the CS (conditioned
stimulus) is paired with the U.S. (unconditioned stimulus; Abramowitz, Deacon, &
Whiteside, 2012). During exposure therapy, the CS is presented without the U.S., often
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resulting in a decreased response to the CS. As a result, the CS now has two meanings (a)
CS means U.S. (excitatory pathway-original learning) and (b) CS means no U.S.
(inhibitory pathway-new learning). Therefore, the original fear memory cannot be erased,
but instead new learning may occur. This alternative new learning between the
conditioned and unconditioned stimulus is referred to as inhibitory learning (Bouton,
1993). In summary, fear learning (acquisition & extinction) has been translated into
exposure-based treatments.
For decades, clinicians have relied on fear response during exposure to determine
treatment progression and success. Recent conclusions suggest that the level of fear
experienced post exposure is both dependent on the strength of the new learning that
occurred during exposure and independent of the level of fear displayed during the
exposure (Craske et al., 2008; Myers & Davis, 2006). However, many of the
aforementioned evidenced-based treatments rely on fear-exhibited during exposure to
provide clinical guidance and determine treatment success. Thus, modern approaches to
PTSD treatment may be more effective by targeting a different mechanism of change
during exposure therapy. Craske et al. proposed an alternative mechanism of change, that
is, the toleration of fear or distress during exposure therapy. Research has found that the
toleration of fear in the presence of the feared stimulus is important to optimizing
inhibitory learning (Craske et al., 2008; Craske & Mystkowski, 2006). This approach of
optimizing inhibitory learning suggests that creating “a violation in expectancies,”
enhances one’s ability to realize that a feared stimulus that resembles threat in fact is not
threatening (Craske et al., 2008, p. 14). Therefore, as basic science develops, researchers
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and clinicians alike, continue to examine which treatments models most effectively target
these processes of change.

Experiential Avoidance and PTSD
In line with the concept that tolerance rather than in-session reduction in fear are
key factors in the treatment of PTSD, there has been considerable research on the role of
experiential avoidance in the development and maintenance of PTSD. Experiential
avoidance is a method of actively avoiding or escaping particular private experiences,
and is inversely related to overall psychological functioning, such that higher rates of
experiential avoidance correlate with poorer psychological functioning (e.g., Hayes,
2004; Walser & Westrup, 2007). Within PTSD, private experiences may include negative
emotional states, traumatic memories, negative thoughts about oneself, others, or the
world, and/or distressing physiological reactions. Interestingly, experiential avoidance
has a paradoxical effect on the development and maintenance of PTSD. On one hand,
avoidance may temporarily alleviate distress related to the unwanted private experiences
and provide a sense of control (Burrows, 2013). On the other hand, this avoidance or
inability to contact the private experience results in a negative reinforcement cycle.
Ultimately, life becomes about escaping or avoiding distress resulting in notable
reduction in positive and meaningful life activities (Thompson & Waltz, 2010; Walser &
Westrup, 2007).
Researchers have shown that experiential avoidance is significantly correlated
with posttraumatic symptomology (e.g., Bluett et al., 2014; Plumb, Orsillo, & Luterek,
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2004). One study examined 160 women who had experienced a sexual assault in addition
to one or more potentially traumatic events. Contrary to predictions, experiential
avoidance and general psychiatric symptoms were equivalently associated to
posttraumatic stress symptoms. However, a particular form of experiential avoidance,
thought suppression was significantly correlated to posttraumatic stress symptoms (Tull,
Gratz, Salters, & Roemer, 2004). A group of studies examined the impact of experiential
avoidance on individuals who have experienced childhood sexual assault. One study in
particular showed that experiential avoidance played a mediating role between childhood
sexual assault and distress (Marx & Sloan, 2002). Research has demonstrated that various
coping strategies, including negative attitudes and thought suppression are related to posttraumatic symptomology. One study showed that experiential avoidance, determined by
negative attitudes towards expression of emotions, was predictive of developing PTSD in
motor vehicle survivors (Nightingale & Williams, 2000) while another study showed
avoidance strategies being predictive of post-traumatic symptomology amongst Gulf War
veterans (Benotsch et al., 2000). Given these findings, experiential avoidance appears to
influence ones’ psychological functioning after experiencing a trauma and likely an
important objective for treatment (Bluett et al., 2014).
As reviewed, treatments for PTSD are not universally effective and dropout rates
amongst veterans are particularly alarming (Garcia et al., 2011). Existing PTSD
treatments such as PE continue to target fear reduction as a process of change. However,
research suggests that alternative processes of change, such as tolerance and acceptance,
might actually be more consistent with the basic research on this topic. Avoidance
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appears to be a common and predominant theme in the development and maintenance of
PTSD as well as moral injury. Therefore, a treatment that promotes acceptance and
decreases avoidance may be effective for the treatment of PTSD and moral injury.
A recent paper by Thompson, Luoma, and LeJeune (2013) explored the
relationship between Acceptance and commitment therapy (ACT) and the treatment of
PTSD. Specifically, the study examined how the principles of ACT both build on
traditional exposure processes as well as enhance inhibitory learning in the treatment of
PTSD. The ACT model highlights the importance of moving beyond tolerance of painful
traumatic memories and the associated internal experiences into acceptance. Acceptance
is the ability to experience thoughts and feelings as they arise. Thus acceptance creates an
experience in which new learning may occur. Notably, this model suggests that exposure
is conducted in order to facilitate valued living rather than symptom reduction (Eifert &
Forsyth, 2005).

Acceptance and Commitment Therapy
As previously written, experiential avoidance, often results in maintaining or
increasing the frequency of the unwanted inner experience, in addition to poor
psychological functioning and a lower quality of life. Alternatively, acceptance-based
interventions promote willingness to experience thoughts, feelings, and emotions, without
changing their form, meaning, or frequency; thereby allowing for engagement in life
regardless of the severity of internal experiences. One such therapy, ACT, has growing
support as an intervention for anxiety disorders (Arch et al., 2012; Bluett et al., 2014;
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Ruiz, 2010). The primary focus is to increase behaviors that are consistent with personal
values while allowing for any given internal experience to be present. This therapeutic
approach emphasizes the willingness to experience unwanted internal experiences while
continuing to behave in a way that is consistent with one’s personal values. Therefore,
ACT aims to alter the function of the thoughts and feelings rather than the content. The
philosophy and theory of ACT suggest that altering the verbal context in which
avoidance behaviors are predominant will lead to behaviors in line with personally
identified values (Hayes, 2004). To provide a more complete understanding of this
therapeutic approach, a brief overview of the philosophical and theoretical assumptions
of this model will be presented.

Philosophy of Science
Functional contextualism, the philosophical underpinnings of ACT, is concerned
with the actions or events in the context by which they occur (Hayes, 1993; Hayes,
Hayes, & Reese, 1998). Functional contextualism encompasses several key components.
One such component indicates that an event must be viewed as a whole event including
the past and current contexts. A second component emphasizes the pragmatic truth
criterion of successful working. Successful working is determined by the consistency in
which the action is in line with one’s values (Hayes, Luoma, Bond, Masuda, & Lillis,
2006). Finally, the unified goal of functional contextualism is to predict and influence
such behaviors (Hayes, 2004). Building on this foundation of philosophy of science, ACT
is grounded in a behavioral theory of language and cognition (Thompson et al., 2013).
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Relational Frame Theory
ACT is rooted in behavior analysis including a “contextualistic theory of
cognition” called relational frame theory (RFT; Hayes, 2004) This theory of human
language and cognition suggests that humans have the ability to arbitrarily relate events
both mutually and in combination and those responses are under contextual control
(Hayes, 2004; Hayes et al., 2006). That is, humans have the ability to respond to both
internal and external stimuli based on properties that are not directly experienced
(Twohig, 2009b). Thus, an individual’s relational responding results from a type of
learning, called relational learning, in which a transformation of stimulus function may
occur (Hayes, 2004). Ultimately, this transformation of stimulus functions results in the
function of one stimulus altering the function of another, possibly unrelated in formal
ways. This relational framing has several clinical implications including the concept of
experiential avoidance. Specifically, RFT allows fear and avoidance responses from one
stimulus to transfer to a seemingly unrelated internal or external stimulus through
relational framing- often leading to psychological inflexibility. For example, during a
patrol a veteran witnessed an explosion in a garbage can on the street corner. Now
anything that may be perceived as “hidden,” evokes a fear response in the veteran, which
results in a large number of stimuli that evoke fear.
Psychological inflexibility is the inability to accept distressing thoughts, feelings,
and emotions as they arise, and not engaging in meaningful actions. Conversely,
psychological flexibility is the ability to contact the present moment by openly accepting
internal and external experiences by behaving in a way that is consistent with one’s
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values (Hayes et al., 2006). ACT targets six functional processes in efforts to broaden an
individual’s psychological flexibility. Independently, the six core processes are effective
targets of treatment that may be applied through experiential exercises and metaphors in
order to increase one’s psychological flexibility (Thompson et al., 2013). One primary
process of ACT, acceptance, is the process of fostering an open, willing attitude, to
experience one’s thoughts, feelings, and emotions without engaging in avoidance
(Luoma, Hayes & Walser 2007). Defusion, opposed to fusion, is the act of observing
one’s thoughts as thoughts, rather than interpreting the content as reality (Luoma et al.,
2007). Written differently, defusion allows a decrease in the literal impact of language
(Twohig, 2012). Contact with the present moment is being connected to internal and
external experiences as they occur rather than events in the past or the future. Self as
context, or the observer-self, is the process of taking a perspective that allows
differentiation between evaluations of self and the actual self (Thompson et al., 2013).
Personally chosen values are fundamental areas of life that provide motivation and
meaning to engage in specific actions (Twohig, 2012). Finally, committed actions are
behaviors that one participates in order to move toward personally identified values
(Hayes et al. 2006). Moreover, a recent meta-analysis on laboratory based studies by
Levin et al. revealed that components of the ACT model (e.g., acceptance and defusion)
increase psychological flexibility and may increase willingness to engage in a distressing
task (Levin, Hildebrandt, Lillis, & Hayes, 2012).
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Effectiveness of ACT for PTSD
ACT has gained support as an effective treatment for a variety of anxiety
disorders (Bluett et al. 2014; Sharp, 2012). While research is limited, an increasing
numbers of case studies have shown promising results for ACT as an intervention for
PTSD. To date, four case studies, one multiple baseline, one group study and one
randomized controlled trial have been conducted utilizing ACT for PTSD.
A preliminary case study conducted by Batten and Hayes (2005) reported the
application of ACT for PTSD and comorbid substance abuse in a 19-year old White
female. Results showed posttreatment improvements through 12-month follow-up,
providing preliminary data for ACT as a treatment for comorbid disorders along with an
in depth conceptualization of the application of ACT for PTSD (Batten & Hayes, 2005).
A second study presented a case of a 51-year-old Vietnam veteran presenting with
posttraumatic stress and depressive symptoms who refused exposure therapy. The veteran
willingly participated in an ACT protocol and actively engaged in committed actions
associated with his personal values (Orsillo & Batten, 2005). A third case study presented
the treatment of a 43-year-old White female with a comorbid diagnosis of PTSD and
depression. Two months prior the individual failed to respond to 20 sessions of traditional
CBT for trauma from a history of physical and verbal abuse. In this case study she
received 21 sessions of ACT. Results showed clinically significant decreases in her
PTSD, depression, and anxiety symptoms. Notably, her scores on the PLC-C, a measure
of PTSD symptoms, decreased from a 67 at time of intake to a 28 at posttreatment, close
to one standard deviation below the clinical cutoff for PTSD. Additionally, scores on the
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BDI-II dropped from a 34 pretreatment to a 4 posttreatment, as well as decreases on the
BAI, reducing from a 38 to 7 by posttreatment. Furthermore, the individual displayed
notable decrease on a measure of psychological flexibility, with AAQ scores decreasing
by 43% from pre- to posttreatment. Interestingly, scores on the PTCI, a measure of
trauma-related thoughts and beliefs, only showed a decrease from sessions 16-21, a point
in treatment in which PTSD symptoms, measured by the PLC-C had decreased by 50%
(Twohig, 2009a).
A recent case study examined the effectiveness of 18, 50-minute, ACT treatment
sessions for an 18-year old female with sexual assault trauma (Burrows, 2013). The early
phases of treatment focused on creating present moment awareness, decreased avoidance
of sleeping, as well as defusion from her thoughts. The middle stages of treatment
targeted avoidance and conceptualization of the self. In the final stages of treatment, the
client continued to work on defusion and acceptance of anxiety, creating a personal
metaphor as anxiety being “a dragon that she had to create space for.” Results from this
study showed improvements on the primary measure of experiential avoidance, AAQ-II,
36 pretreatment, 26 at the final treatment session, and 26 at an 8- month follow-up.
Thought suppression measured by the White Bear Suppression Inventory decreased from
73 at pretreatment to 57 at posttreatment, and to 48 at 8-month follow-up. The individual
displayed significant reductions in trauma symptoms as measured by the Trauma
Symptom Checklist with a score of 70 at pretreatment to a score of 45 at the final session
and 35 at an 8-month follow-up. Notably the study showed improvements on the VLQ
(valued living questionnaire). Finally, one study has been conducted utilizing ACT for
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adolescents with posttraumatic stress (PTS). A multiple-base line design was utilized to
treat seven adolescents with PTSD (four in the community and three at a residential
treatment setting). Results showed preliminary support for ACT with a 73.7% mean
reduction in self-reported PTSD symptoms and nearly 60% mean reduction in clinician
rated measures of PTSD (Woidneck, Morrison & Twohig, 2014).
To our knowledge, ACT has been applied once in a group treatment setting for
veterans (Williams, 2007) and larger unpublished randomized-control trial treating
veterans for trauma related stress. However, to date no data is available regarding the
finding of these studies.
In summary, PTSD is a paramount issue amongst U.S. active service members
and veterans. Additionally, moral injurious events may be directly related to the
development and maintenance of extreme psychological distress, such as PTSD, in U.S.
military personal and veterans. While evidence-based treatments for PTSD exist, they are
not universally effective. Additionally, purported mechanisms of change from these
existing treatment models have shifted with recent research. Specifically, a model of
toleration or acceptance may be a more viable approach for treating PTSD than fear
reduction. Thus, acceptance and mindfulness-based interventions have promising
implications as an alternative or second line intervention for PTSD amongst veterans. For
these reasons, the investigation of ACT as a next-step intervention for veterans with
chronic PTSD is warranted.
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CHAPTER III
METHODS

Design
This study implemented an 8-week group intervention to examine the
effectiveness of ACT for Veterans diagnosed and previously treated for PTSD. A group
intervention was advantageous considering the continual need for mental health services
for veterans with PTSD (e.g., Sripada et al., 2016). Enrollment for this study was
continuous; however, a closed-group design was utilized (i.e., veterans were only allowed
to join a group at the beginning of an 8-week group cycle). In total four, 8-week groups
were conducted between June 2015 and May 2016, in the PTSD Clinic at the George E.
Wahlen Department of Veterans Affairs Medical Center in Salt Lake City, Utah.
Participants were referred by their provider, but ultimately self-selected to join the
group. The intended sample size for this study was 40 participants total, with a minimum
of 5 veterans per group. This number was determined by an initial power analysis
conducted through G*Power software with an alpha level of .05 and a power of .80. The
preliminary power-analysis, using an effect size of .25, specified a sample of 28. An
actual sample of 33 participants was enrolled.

Participants
Approximately 49 veterans were referred to participate in the group. Of those
referred, a total of 33 veterans enrolled in the study. Several veterans referred to the
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group were unable to participate due to work schedules, the time and day of the group,
and transportation. Many requested to be contacted for the next group. Three of the
referred veterans indicated that they were uninterested in participation.
To be eligible to participate in the group, veterans had to meet the following
criteria: (1) the veteran must have been over the age of 18, (2) the veteran must have been
diagnosed with PTSD or subclinical PTSD, and (3) the veteran must have enrolled and
completed an evidenced-based treatment for PTSD. An initial diagnosis for PTSD or
subclinical PTSD was determined through an official in-person psycho-diagnostic
assessment conducted by a member of the PTSD Specialty Clinic at the Salt Lake City
Veterans Affairs Medical Center. For this study, diagnostic status was reassessed and
determined by the PCL-5. Additionally, veterans must have completed an evidencedbased treatment for PTSD prior to participation in the group. Evidenced-based treatments
for PTSD include prolonged exposure therapy, cognitive processing therapy, and eye
movement desensitization and reprocessing. Participants were excluded if they (1) were
currently enrolled in an EBT group treatment, (2) were experiencing psychosis, or (3)
experienced a cognitive disability that would inhibit their ability to participate in the
study. The study was approved by the Institutional Review Boards at the University of
Utah and Utah State University as well as the SLC Veteran Affairs Office of Research.

Procedure

Recruitment
Veterans were recruited through referrals from mental health providers at the VA
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(see Appendix A). In order to maximize referrals, announcements regarding the group
were made during weekly team meetings for therapists on the PTSD team. In addition,
flyers were posted throughout the VA campus and the community. All referrals by mental
health providers were added to the ongoing recruitment list. Referred veterans were
contacted by telephone one month prior to a projected group start date. Study personal,
invited veterans to participate in the group, provided information regarding the goals and
therapeutic approach of the group, and answered any questions or concerns posed by the
potential participants. Veterans uninterested in the group were offered referrals and those
unable to attend were rolled over to the next group’s referral list.
Veterans who were interested in the group were invited to attend the first session.
All groups were held in a group room in Building 16 on the George E. Wahlen
Department of Veterans Affairs Medical Center campus. The group was conducted by
Ellen Bluett, a graduate student at Utah State University, Dr. Brandon Yabko, Dr. James,
Asbrand, and Dr. Sara Owen - staff psychologists at the Salt Lake City, Veterans Affairs.
At session one, individuals were provided information regarding the option to
participate in the research study. A verbal announcement was made regarding the purpose
of the research. All interested veterans were provided an informed consent cover letterwhich outlined the details of the study, including risk and benefits of participation,
confidentiality, and data collection. Prior to data collection, all remaining questions were
answered and study personal clearly stated that veterans could participate in the group
without participating in the research study. All veterans who attended the first session
agreed to research participation.
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Data Collection and Storage
Once consented, veterans were asked to complete a pretreatment assessment
battery, which included a well-established measure of PTSD, overall functioning,
distress, and background information (see Measures section). To ensure confidentiality,
each veteran was provided a unique participant ID number, which was used throughout
the course of the research study. All identifying information for the veteran was kept
separate from the study data.
Assessment measures were provided in paper and pencil format (Appendix B).
Assessment procedures are outlined in Table 1. To determine the effectiveness of the
group intervention, data was collected at three time-points including pretreatment
(session 1), posttreatment (session 8), and follow-up (1-month). Pretreatment assessments
were collected prior to the start of session one and posttreatment assessment measures
were collected at the end of session eight. In addition, due to time constraints and an
awareness of participate burden, a comprehensive background information packet was
administered at the end of session 1. Veterans were asked to complete and return the
packet at the next session. One month after the final treatment session, veterans were sent
a follow-up questionnaire packet in the mail, along with a pre-addressed, pre-paid
envelope. Veterans were asked to complete the follow-up questionnaire packet and return
it to the VA. To assess for processes of change, participants were asked to complete two
measures (AAQ-II, VQ) at the end of session three and session six. Finally, treatment
integrity measures were administered at the end of each session in efforts to assess for
treatment adherence by study personal (Appendix B).
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Table 1
Assessment Timeline
Week 1

Week 3

Pretreatment

Acceptance and Action
Questionnaire-II , Valuing
Questionnaire

Week 6

Week 8

Week 12

Acceptance and Action
Questionnaire-II , Valuing
Questionnaire

Posttreatment

Follow-Up

Treatment
The treatment administered was an adaptation of a pre-existing ACT manual
developed for adult individuals with PTSD (Walser & Westrup, 2007). The original
protocol was modified to best fit a group format for veterans. Because the focus of this
group was not on trauma processing, the trauma-processing components were excluded
from this treatment. Treatment consisted of 8-weekly, 2-hour sessions of group therapy,
which followed the ACT protocol. The aims of the treatment protocol included (1)
increasing psychological flexibility, (2) decreasing experiential avoidance, and (3)
increasing behaviors that were consistent with self-identified values. The full treatment
manual used for this study can be found in Appendix D.
Table 2 includes a brief overview of the treatment components and exercise
covered at each treatment session. After session one, each session followed a similar
format. The sessions began with a mindfulness exercise and check-ins regarding
behavioral commitments. The majority of each session was spent introducing a treatment
component with accompanying metaphors/experiential activities. Each session ended
with each veteran setting a new behavioral commitment for the week.
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Table 2
ACT for Posttraumatic Stress
Session Treatment components
1

2

3

4

5

6

Exercises/content

Informed consent
Confidentiality and group
rules

Rules/guidelines introduced to help participants feel safe and comfortable
in the group.

Vitality, values

Focus of treatment is not on symptom reduction or trauma processing,
instead focus on doing what matters. ACT is a radically different approach
than CPT, PE, EMDR.

Clipboard Metaphor
Goal of therapy: Triflex model of Vitality: doing what matters, being
present, and willingness.

Mindfulness/present moment

Breathing meditation

Creative hopelessness

Explored past attempts to control, alter, change certain PTSD symptoms;
Examined cost and effectiveness of trying to control, alter, change. PTS
symptoms.

Creative Hopelessness

Behavioral commitment

Set weekly goal linked to a valued domain

Mindfulness & check-in

Progressive Muscle Relaxation

Control as the problem/
willingness

Reviewed the paradoxical effect of trying to control thoughts feelings
emotions.

Man in the Hole
Discussed why humans try to control thoughts, feelings, emotions
Introduced alternative to control.

Tug of War

Behavioral commitment

Set weekly goal linked to a valued domain

Mindfulness & check-in

Welcome Anxiety My Old Friend

Willingness

Introduced the concept of willingness- the opposite of control/avoidanceFinger-trap, Annoying Uncle Bob, Perfect anxiety detector

Behavioral commitment

Set weekly goal linked to a valued domain

Mindfulness & check-in

Leaves on a stream

Defusion

Discussed fusion vs. defusion; Discussion on our “programming” and not
taking our thoughts literally or as “Truth”

2 computers, Milk, Milk, Milk

Behavioral commitment

Set weekly goal linked to a valued domain

Mindfulness & check-in

Take your mind for a walk

Defusion

Reviewed handouts from the “Happiness Trap” in order to increase
cognitive defusion, words and thoughts are just words and thoughts.

Behavioral commitment

Set weekly goal linked to a valued domain

(table continues)

34
Session Treatment components
7

Exercises/content

Mindfulness & check-in

Self-compassion exercise

Self-as-context

Introduced the concept of the observer self and the concept that you are
not your thoughts.

Chessboard Metaphor
Set weekly goal linked to a valued domain

8

Mindfulness & check-in
Acceptance, values

Reviewed concepts that you can move towards your values with
passengers on your bus (thoughts, feelings, emotions)

Passengers on a Bus

Maintenance

Bill of Rights

Post-assessment
Note. Italicized items are metaphors or exercises published in Walser & Westrup (2007).

Measures
Diagnostic Measures
Background/Demographics. The background information form collected baseline
demographics about the veteran including sex, age, marital status, educational history,
medication, previous treatment, and basic military characteristics (e.g., era, branch).

Outcome Measures
PTSD Checklist (Blanchard, Jones-Alexander, Buckley, & Forneris, 1996;
Weathers, Litz, Herman, Huska, & Keane, 1993). The PTSD Checklist (PCL-5) is a selfreport measure that is intended to screen for PTSD. Items are reported on a 4-point Likert
scale 0 (not at all) to 4 (extremely bothered). The PLC-5 measure is used during clinical
assessment to evaluate the validity of symptoms endorsed via self-report. Items rated a 2
or above are considered significant symptoms and considered meeting diagnostic criteria.
The cutoff method indicates that a score of 38 or above on the PCL-5 meets diagnostic
criteria for a PTSD diagnosis. Cronbach’s alpha for this study was α = .92.
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Patient-Health Questionnaire (Beck, Steer, & Brown, 1996). The Patient Health
Questionnaire (PHQ-9) is a commonly used brief self-report measure assessing for
depression. The measure specifically assesses for depressive symptoms that are derived
from the diagnostic criteria for Major Depressive Disorder. The 9-item measure is scored
on a 4- point Likert scale assessing frequency of symptoms ranging from 0 (not at all) to
3 (nearly every day) Scores range from 0 to 27 with higher scores signifying greater
depression. Symptom severity cut-off scores have been established into the following
categories: 0-4 (no depression), 5-9 (mild depression), 10-14 (moderate depression), 1519 (moderately severe depression) and scores from 20-27 (severe depression). The
measure has been found to have good internal consistency (α = 0.86-0.89) and excellent
test-retest reliability (r =.81-.96; Löwe, Unützer, Callahan, Perkins, & Kroenke, 2004;
Sripada et al., 2016). Cronbach’s alpha for this study was α = .88.
World Health Organization Well-Being Index (WHO-5; Beck et al., 1996). The
WHO-5 is a self-report measure assessing well-being over the past two weeks. The 5item measure is scored on a 6-point Likert scale ranging from 0 (at no time) to 4 (all of
the time). Scores range from 0 to 25 with higher scores signifying greater well-being. A
percent may be calculated by multiplying the total score by 4—a percentage of 0 equals
the worst possible well-being and a percentage of 100 equals the best possible well-being.
The measure has been found to have good internal consistency (α = .84; Bech, Olsen,
Kjoller, & Rasmussen, 2003). Cronbach’s alpha for this study was α = .84.
Internalized Shame Scale (ISS; Cook, 1996). The ISS is a 24-item self-report
assessment that measures internalized shame, an emotion of negative self-evaluation, is
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rated on a 5-point Likert scale ranging from 0 (never) to 4 (almost always) (del Rosario &
White, 2006). An additional 6-items assessing self-esteem are often included in this
measure. The measure has shown to have good internal consistency ranging from a
clinical sample (α = .87 to α = .90; Rybak & Brown, 1996) and good test-retest
reliability, (r = .81; del Rosario & White, 2006). Cronbach’s alpha for this study was α =
.96.
Quality of Life Scale (Burckhardt, Woods, Schultz, & Ziebarth, 1989). The
Quality of Life Scale is a measure that determines overall life satisfaction. This 16-item
questionnaire requires an individual to rate areas of satisfaction (e.g., close friends) on a
7-point Likert scale, 1 (terrible) to 7 (delighted). Total scores indicate current quality of
life with higher scores being associated with better quality of life. This measure has
shown both good internal consistency (α = .89 and α =.92) and good test-retest reliability
(r =.78-.84; Burckhardt et al., 1989). Cronbach’s alpha for this study was α = .92.
Moral Injury Events Scale (MIES; Nash et al., 2013). The MIES is a measure of
the number of exposures to events perceived to violate moral beliefs or betrayal by
oneself or another person. This 9-item measure is scored on a 6-point Likert scale, 1
(strongly agree) to 6 (strongly disagree). Higher scores indicate a greater number of
morally injurious events experienced. A preliminary psychometric validation study
examined responses on the MIES 1 week and 3 months post deployments in a sample of
533 Marines. Test-retest reliability was not found to be statistically significant. Results
showed excellent internal consistency (α = .90). Importantly the MIES showed
discriminant validity (r =.08) from the CES (a measure of combat exposure), thus
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confirming that morally injurious events may occur independent from combat exposure.
As predicted the MIES was positively correlated with the BDI-II (r = .40) and the PTSD
checklist (r = .28). Cronbach’s alpha for this study was α = .83.
Valuing Questionnaire (VQ; Smout, Davies, Burns & Christie, 2014). The VQ is
a self-report measure assessing values-driven behaviors over the past week. This 10-item
measure is scores on a 7-point Likert scale and consists of two factors: (a) progress and
(b) obstruction. The progress subscale measures to what extent an individual engaged in
behaviors that are consistent with personal values over the past week. The obstructed
subscale measures to what extent cognitions and emotions prohibited values consistent
behavior over the past week. Both the progress and obstructed subscales have shown
good internal consistency (0.86) and (0.83), respectively. Cronbach’s alpha for this study
was α = .77 for progress and α = .72 for the obstructed subscale.

Process of Change Measures
The Acceptance and Action Questionnaire-II (AAQ-II; Bond et al., 2011). The
AAQ-II is a seven-item self-report measure that assesses experiential avoidance and
psychological flexibility. This 7-item Likert scale, 1(never true) to 7 (always true). It is
the only existing measure that directly measures experiential avoidance. Higher scores
indicate greater psychological inflexibility. While no established cutoff exists, total
scores between 24-28 suggest greater psychological flexibility and less experiential
avoidance. The AAQ-II has shown good test-retest reliability (r = .81) as well as good
internal consistency (α = .78 to 87). Cronbach’s alpha for this study was α = .94.
Believability of Anxious Feelings and Thoughts (BAFT; Herzberg et al., 2012).
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The BAFT is a 16-item self-report measure of cognitive fusion for anxious thoughts,
feelings, and bodily responses. The BAFT has shown good internal consistency amongst
an undergraduate sample (α = .90) and a highly anxious sample (α = .91). Additionally,
the measure has good test-retest reliability over a 12-week period (r = .77). Cronbach’s
alpha for this study was α = .95 for the total scale.

Treatment Acceptability
Treatment Evaluation Inventory Short-Form (TEI-SF; Kelley, Heffer, Gresham,
& Elliott, 1989). The TEI-SF is a 7–item self-report questionnaire assessing treatment
acceptability. The original TEI-SF was a 9-item measure; however, two items have been
excluded as they do not apply to the population within this study. This questionnaire is
measured on a 5-point Likert scale ranging from 0 (strongly disagree) to 5 (strongly
agree). Scores are totaled and those above a 21 indicate a greater amount of treatment
acceptability. The original TEI-SF has shown good internal consistency (α = .85).

Treatment Integrity/Adherence/Fidelity
The Veterans Affairs follows government security and confidentiality procedures,
therefore video and audio recording of sessions was not possible for this study. To
determine treatment adherence, a checklist was administered at the end of each session to
assess whether each treatment objective was covered in session. Veterans were required
to circle “yes,” “no,” or “not sure” to indicate whether each treatment objective was
covered during that session. Total scores and percentages were calculated for each
treatment session, across the four treatment groups.
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While treatment adherence options were limited, treatment checklists were
administered at the end of each session. Results showed that according to veterans across
groups: 93.75% of the proposed material was covered at session 1, 95.65% at session 2,
95.5% at session 3, 90% at session 4, 97% at session 5, 95% at session 6, 100% at session
7, and 97% at session 8. Overall, treatment adherence ratings were above 90% across all
groups and all sessions.
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CHAPTER IV
RESULTS

Data Analytic Strategy
First, the participant flow was prepared. Second, independent sample t test and
chi-square analyses were conducted to determine equivalence between treatment
completers and non-completers on pretreatment variables including demographics,
military specific demographics, and primary outcome variables. Third, to assess response
to treatment - change scores were calculated on the PCL-5 from pretreatment to
posttreatment. Fourth, to assess change on primary outcomes and secondary outcomes
over time, a series of univariate analyses of variance (ANOVAs) were conducted. Fifth,
correlations were calculated between pretreatment primary and secondary variables to
assess associations between these variables. Sixth, to examine whether pretreatment
symptoms predicted change on PTSD symptoms—simple logistic regressions were
performed. Seventh, bivariate correlations were conducted to examine the relationship
between process of change measures (pretreatment to mid-treatment) and posttreatment
PTSD symptom severity. The analyses for this study were performed utilizing SPPS
Version 23.0 and MPlus Version 7.0. Visual graphs were prepared utilizing R statistical
package.

Missing Data
The dropout rate amongst group participants (42%) was on par with the national
average for PTSD treatments. Dropout rates for PTSD treatment—without a specific
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trauma focused component—ranged between 0-48% (Imel et al., 2013) and between 1239% (Steenkamp & Litz, 2013). A meta-analysis estimated the average dropout from
individual treatment for PTSD to be 18%, with group therapy increasing the dropout rate
by 12% (Imel et al., 2013). While other studies suggest that attrition rates are lower for
trauma-focused groups compared to individual therapy (Barrera, Mott, Hofstein, & Teng,
2013).
Because of the large amount of dropout from pretreatment to posttreatment to
follow-up, missing data were handled through multiple imputation in Mplus (Version 7.0;
Muthén & Muthén, 2012). The Mplus statistical package can produce multiple
imputations of missing data through Bayesian analysis -which results in multiple data sets
for analysis (Muthén & Muthén, 2012). Each imputed data set has a unique set of
replacement values for missing data. For this study, five imputed data sets were created
with 10,000 iterations. Following imputation, the data was visually scanned for negative
values, missingness, and values outside the range of the measure, none of which were
detected. Total scores from each imputed data file were summed and averaged across the
five models. The mean obtained was used in subsequent analyses. It is important to note
that while multiple imputation is a viable statistical approach for missing data, precaution
should be taken in interpreting the data, as there was a small sample size and nearly 40%
of the study data was missing at posttreatment.
Overall missing data across each study variable was low (<5%). In the rare
occurrence of missing data on an item of a study variable- those measures with less than
10% of the items missing, a mean score and total score was computed for that measure

42
using data points that were present.

Test of Normality and Outliers
Tests of normality were conducted on all study variables. Of the outliers detected,
all were associated with one participant. This participant reported experiencing a
significant amount of depression, during the course of treatment, and reported elevated
scores compared to the rest of the sample. Due to the exploratory nature of this study this
veteran’s data was included in the analyses.

Participant Flow
Approximately 49 individuals were referred to the study. Initially 33 attended
session one and completed the pretreatment assessment. At session two, 30 individuals
remained in treatment. Nineteen individuals completed the posttreatment assessment. Of
note, a majority of the sample completed more than half of the treatment with 24
individuals completing session 5. Table 3 displays the number of participants remaining
in the study at each session. Finally, 12 individuals completed 1-month follow-up
questionnaires. Figure 1 displays the flow of participants across the course of the 12week study.
Table 3
Number of Participants Remaining in Treatment by Session

Participants

Session
1
33

Session
2
30

Session
3
27

Session
4
25

Session
5
24

Session
6
23

Session
7
20

Session
8
19
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Figure 1. Participant flow.

Participant Characteristics
A summary of participant characteristics for the total sample is provided in Table
4. Of the 33 participants in this study a majority were male 87.9% (n = 29). The mean age
of the sample was 49.6 (16.31) with ages ranging between 24 and 70 years old. A
majority of participants identified as White 84.8% (n = 28). A majority of the sample was
married 72.7% (n = 24). Furthermore, a majority of the sample was educated with some
college 30.3% (n =10), an associate’s degree 27.3% (n = 9) or a bachelor’s degree, 21.2%
(n = 7).

Military Characteristics
A summary of participant’s military characteristics is presented in Table 5. Of the
thirty-three participants enrolled in the study 51.5% were OEF/OIF veterans (n = 17)
36.4% were Vietnam veterans (n = 12), 6.1% were Desert Storm veterans (n = 2), and
6.1% served in more than one era of war (n = 2). Veterans varied in their military branch;
45.5% were in the Army (n = 15), 21.2% were in the Marines (n = 7), 9.1% were in the
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Air Force (n = 3), 9.1% were in the Army Reserves (n = 3), 6.1 % were in the Navy (n =
2), 6.1% were in the Army National Guard (n = 2) and 3.0% were in the Air Force
Reserves (n =1). The number of years in service also varied, with a majority of veterans
serving between one and 5 years (42.4%; n = 14), 36.4% serving between 6 and 10 years
(n = 12), 6.1% serving between 11 and 15 years (n = 2) and 15.2% serving 21 years or
more in service (n = 5). Of the veterans enrolled in the study, a majority served one
deployment 60.6% (n = 20), 8% served two deployments (n = 8), while 15.2% served
three or more deployments (n = 5). All but three individuals (9.1%) were service
connected, which indicated that they received some financial compensation for disability
from the Veterans Affairs Administration.

PTSD Diagnostic Status and PTSD
Treatment Summary
The PCL-5 serves a variety of purposes including monitoring symptom change
over the course of treatment, screening individuals for PTSD, and making preliminary
diagnoses of PTSD. To determine diagnostic status, the guidelines for the PCL-5 were
followed. That is, an item rated a “2” or greater was considered an endorsed symptom. To
meet criteria for a provisional PTSD diagnosis individuals must have endorsed: one
cluster B item (items 1-5), one cluster C item (items 6-7), two cluster D items (items 814), and two cluster E items (15-20) on the PCL-5 self-report measure. While all of the
veterans enrolled in the study had received a prior diagnosis of PTSD, 78.8% (n = 26)
met criteria at session one, while the other 21.2% (n = 7) met criteria for subclinical
PTSD. All veterans enrolled in the study had enrolled and completed an evidenced-based
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treatment for PTSD, 60.6% (n = 20) completed CPT, 36.4% (n = 12) completed PET, and
only one veteran completed EMDRT.

Completer Versus Dropout Differences

Summary of Demographic by Completer
Status
To examine differences in demographic characteristics between treatment
completers and noncompleters, independent sample t tests and chi-squares were
conducted. Results are shown in Table 4. As can be seen, there appeared to be no
statistical difference in age, gender, race and ethnicity, marital status, education,
employment, or religion between completers and noncompleters. Therefore, to our
knowledge, there is no evidence of treatment dropout based on these variables. Last, no
adjustments to the data were made.

Summary of Military Characteristics by
Completer Status
To examine differences in military demographic characteristics between treatment
completers and non-completers, independent sample T-tests and chi-squares were
conducted. The results are presented in Table 5. Again, there appeared to be no statistical
difference in PTSD diagnostic status, era, number of deployments, number of years in
service, or type of PTSD treatment previously received. From these analyses, there no
evidence suggests that treatment dropout was related to these variables, therefore no
adjustments to the data were made.

3

Female

4
6
3
1
1

Some College

Associates

Bachelors

Some Graduate

M.A./M.S.

2
14
2
1

Single

Married

Divorced

Separated

Marital Status

4

High School/GED

Education

Age (years)

16

Male

Gender

Characteristic

5.3

10.5

73.7

10.5

5.3

5.3

15.8

31.6

21.0

21.0

15.8

84.2

53.26

15.55

Completed (n = 19)
─────────────────
n
%
M
SD

2

0

10

2

0

0

4

3

6

1

1

13

14.3

0

71.4

14.3

0

0

28.6

21.4

42.9

7.1

7.1

92.9

45.5

16.31

Dropout (n = 14)
─────────────────
n
%
M
SD

Summary of Demographic Statistics by Completer Status

Table 4

3

2

24

4

1

1

7

9

10

5

4

29

9.1

6.1

72.7

12.1

3.0

3.0

21.2

27.3

30.3

15.2

12.1

87.9

49.6

16.31

Total (n = 33)
─────────────────
n
%
M
SD

.46

.45

.72

.62

p

(table continues)

2.30 (3)

4.7 (5)

-1.4 (31)

.57(1)

χ² (df) or t (df)

46

4
4
6

Full Time

Disability

Retired

1

Pacific Islander

6
2
4
7

LDS

Catholic

Protestant/Christian

Not Specified

Religion

2

15

White

Hispanic

1

Black

Race/ethnicity

4
1

Unemployed
Part Time

Employment

Characteristic

36.8

21.1

10.5

31.6

5.3

10.5

78.9

5.3

31.6

21.1

21.1

21.1
5.3

Completed (n = 19)
─────────────────
n
%
M
SD

5

4

2

4

0

1

13

0

2

3

5

3
1

35.7

28.6

14.3

21.4

0.0

7.1

92.9

0.0

14.3

21.4

35.7

21.4
7.1

Dropout (n = 14)
─────────────────
n
%
M
SD

12

8

4

9

1

3

28

1

8

7

9

7
2

36.4

24.2

12.1

27.3

3.0

9.1

84.8

3.0

24.2

21.2

27.3

21.2
6.1

Total (n = 33)
─────────────────
n
%
M
SD

5.9 (3)

1.76 (3)

1.68 (4)

χ² (df) or t (df)

.90

.62

.

.80

p

47

48
Table 5
Summary of Military Statistics by Completers versus Noncompleters

Characteristic
Era
Desert Storm
Desert Storm & OEF/OIF
OEF/OIF
Vietnam
Vietnam & OEF/OIF
Deployments
One
Two
Three
Four
Years in service
1-5
6-10
11-15
16-20
> 21

Completed
(n = 19)
──────
n
%
1
1
8
8
1

5.3
5.3
42.1
42.1
5.3

Dropout
(n = 14)
──────
n
%
1
0
9
4
0

7.1
0.0
64.3
28.6
0.0

Total
(n = 33)
──────
n
%
2
1
17
12
1

p
.61

.28(3)

.96

2.60(3)

.46
.

1.06(2)

.59

6.1
3.0
51.5
36.4
3.0

11
5
2
1

57.9
26.3
10.5
5.3

9
3
1
1

64.4
21.4
7.1
7.1

20
8
3
2

60.6
24.2
9.1
6.1

9
5
1
0
4

47.4
26.3
5.3
0.0
21.0

5
7
1
0
1

35.7
50.0
7.1
0.0
7.1

14
12
2
0
5

42.4
36.4
6.0
0.0
15.2

PTSD Treatment
Cognitive processing therapy
12
63.2
8
57.1 20
Prolonged exposure therapy
6
31.6
6
42.9 12
Eye movement desensitization
1
5.3
0
0.0
1
and reprocessing
Note. OEF/OIF = Operation Enduring Freedom, Operation Iraqi Freedom.

χ² (df) or t (df)
2.70(4)

60.6
36.4
3.0

Primary and Secondary Variables
The primary outcomes of interest for this study included: PTSD symptoms
(measured by the PCL-5), quality of life (measured by the QOLS), and valued living
(measured by the VQ). The secondary outcomes of interest for this study included
depression (measured by the PHQ-9), shame (measured by the ISS), and moral injury
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(measured by MIES). See Appendix C for visual representation of data Last, processes of
change measures for this study included cognitive defusion (measured by the BAFT) and
psychological flexibility (measured by the AAQ-II).

Summary of Outcome Variables by
Completer Status
To examine differences in primary outcomes at baseline between treatment
completers and noncompleters, a series of independent samples t tests were conducted on
all primary, secondary, and process measures at pretreatment. Table 6 provides the
means, standard deviation, and p values for pretreatment measures for completers,
noncompleters and the total sample. Results showed that completers and noncompleters
Table 6
Summary of Outcomes by Completers Versus Noncompleters
Completers
(n = 19)
──────────

Dropout
(n = 14)
──────────

Total
(n = 33)
──────────

Variable

Mean

SD

Mean

SD

Mean

SD

t

df

p

PCL-5

45.69

16.20

44.23

14.45

45.10

15.26

-2.68

31

.79

-.025

31

.98

PHQ-9

14.84

5.92

14.29

7.40

14.61

6.50

-2.40

31

.81

WHO-5

9.32

4.95

9.93

3.50

9.60

4.34

.39

31

.70

PTSD dx

ISS

49.05

20.84

54.64

23.50

51.43

21.82

.72

31

.48

QOLS

61.80

16.24

62.21

20.70

62.00

17.94

1.57

31

.10

AAQ-II

32.05

10.20

31.86

10.62

31.97

10.21

-.05

31

.96

VQ progress

15.79

5.63

15.21

5.90

15.67

5.74

-.13

31

90

VQ obstruction

16.90

5.42

18.00

5.49

17.36

5.40

0.58

31

.57

BAFT somatic concerns

19.10

7.85

20.8i6

6.6

19.84

7.28

0.68

31

.50

BAFT negative evaluation

26.70

9.55

31.14

9.13

28.58

9.50

1.35

31

.19

BAFT emotion regulation

24.60

7.65

27.30

6.50

25.73

7.20

1.07

31

.29

Moral injury transgressions

17.86

9.31

16.40

6.71

17.23

8.22

-5.04

31

.62

7.16

3.65

9.00

2.80

7.94

3.40

1.57

31

.13

Moral injury betrayal
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did not significantly differ on primary and secondary variables of interest at pretreatment.
As before, no adjustments were made to the data.

Statistical Approach on Main Analysis
To assess the effectiveness of an ACT intervention for veterans with PTSD/
subclinical PTSD, individual rates of positive response were calculated using three
methods. Response rates were the percentage of veterans who could be classified as
“responders” to treatment. Following guidelines presented by Loerinc et al. (2015)
multiple modalities are best when determining clinically significant change (Loerinc et
al., 2015). First, the degree of change from baseline was calculated by simply taking the
difference between pre- and posttreatment PCL-5 scores. Following recommendations by
the National Center for PTSD, to determine a clinical change on the PCL for the DSMIV, a 5-point change was used as a minimum score to determine “response to treatment”
and a 10-point change was used to determine if change was “clinically meaningful.”
While change scores have yet to be determined for the PCL-5, research suggests that they
will be in the similar range to the PCL for DSM-IV (e.g., Blevins, Weathers, Davis,
Witte, & Domino, 2015; Bovin et al. 2015; Wortmann et al., 2016).
Next, the reliable change index (RCI; Jacobson & Truax, 1991) was calculated for
the PCL-5. The RCI is a more stringent method for determining response to treatment.
The RCI aims to calculate the standard error of the difference between pretreatment and
posttreatment scores, identifying the spread of the distribution of change scores if no real
change had occurred. Thus, an RCI offers a measurement of change in standardized units,
such that an RCI >1.96 would reflect statistically significant change posttreatment.
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Third, we utilized a clinical cut-off score, to identify the veterans who decreased
below the clinical range on the PCL-5. The National Center for PTSD suggests a cutpoint of 33 until further psychometric evaluation has been conducted on the PCL-5
(Weathers et al., 2013).
To examine changes on the main outcomes measures a series of one-way repeated
measures analysis of variance (ANOVAs) were conducted. One-way repeated measures
ANOVAs (within-subject ANOVAs) were used to determine whether there was a
statistically significant difference between pretreatment, posttreatment, and follow-up
means on the main outcomes of interest.

Primary Outcome Variables
Research Question 1: (a) Is ACT an effective treatment for veterans with PTSD or
subclinical PTSD?
Of the 19 individuals who completed treatment, seventeen completed the PCL-5,
in its’ entirety. Results showed 64.7% of the sample (n = 11) showed a response to
treatment, utilizing the 5-point cut-off, while 35.3% did not (n = 6). Utilizing the 10-point
cut-off to determine clinically meaningful change, results showed that 35.3% of the
sample (n = 6) showed a clinically meaningful change, while 64.7% did not (n = 11).
Lastly, results showed that 23.5% of the sample (n = 4) showed statistically significant
change, utilizing the RCI > 1.96 cutoff. Because the purpose of this study was
exploratory, along with the small sample size, the 5-point change score, indicating a
significant response to treatment was used in the subsequent analyses.
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Research Question 1b. Does ACT positively impact PTSD symptom severity,
quality of life, valued living, depression, shame, and moral injury?
One-way repeated measures ANOVAs were implemented to determine if primary
outcomes of interest progressed in the predicted direction from pretreatment to
posttreatment to follow-up. Table 7 presents means and stand deviations for all primary
and secondary outcome measures.
A one-way repeated measures ANOVA was conducted to compare the effect of
an ACT intervention on PTSD symptoms (PCL-5) from pretreatment to posttreatment to
follow-up. As predicted, results revealed a significant effect of time on PTSD symptoms,
F(2, 64) = 3.40, p = .04, partial η2 = .096. Post hoc test of multiple comparisons, using
Table 7
Outcome Means and Standard Deviations from Pretreatment, Posttreatment, and FollowUp

Variable

Pretreatment
(n = 33)

Posttreatment
(n = 33)

Follow-up
(n = 33)

M

SD

M

SD

M

SD

45.07

15.27

40.52

14.02

40.97

18.91

61.97

16.10

64.60

13.75

60.69

14.76

13.03

5.82

11.38

5.24

14.67

8.33

51.42

21.82

52.79

22.23

54.10

23.28

17.23

6.27

14.86

6.77

19.77

6.63

7.94

2.80

8.10

2.50

9.33

4.10

Primary outcomes
PTSD symptoms (PCL-5)
Quality of life (QOLS)
Secondary outcomes
Depression (PHQ-9)
Shame (ISS)
Moral injury (MIES)
Transgression
Betrayal

Well-Being (WHO-5)
9.60
4.34
13.07
4.60
8.74
5.01
Note. PCL-5 = Posttraumatic Stress; QOLS = Quality of Life Scale; PHQ-9 = Patient Health Questionnaire;
ISS = Internalized Shame Scale; MIES = Moral Injury Events Scale; WHO-5 = World Health Organization
Well-Being Index.
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the Sidak corrections, indicated that PTSD symptoms significantly decreased from
pretreatment (M = 45.07, SD = 15.27) to posttreatment (M = 40.52, SD = 14.02; p =
.022), however the effect of time on PTSD symptoms did not maintain from pretreatment
to follow-up (p = .15). A Cohen’s d effect size was calculated comparing pretreatment to
posttreatment PTSD symptom severity scores. We followed the formula for a Cohen’s d
effect size by subtracting the mean scores at posttreatment from the mean scores
pretreatment divided by the standard deviation. Results showed a small to moderate
effect size, Cohen’s d = 0.31. Taken together, these results suggest that an ACT
intervention was effective in reducing PTSD symptoms pre-to post- treatment; however,
these gains did not maintain to follow-up.
A one-way within subjects ANOVA was conducted to compare the effect of an
ACT intervention on quality of life (QOLS) from pretreatment to posttreatment to followup. Results revealed a significant effect of time on quality of life, F(2, 64) = 4.01, p =
.023, partial η2 = .11. However, post hoc test of multiple comparisons, using the Sidak
corrections, indicated that quality of life did not significantly improve from pretreatment
(M = 61.97.07, SD = 16.10) to posttreatment (M = 64.60, SD = 13.75) (p = .20), while the
difference between quality of life from pretreatment to follow-up was significant (p =
.005). Contrary to predictions, these results suggest that an ACT intervention did not have
an overall positive effect on a measure of quality of life from pre- to posttreatment and
follow-up.
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Secondary Outcome Variables
To determine the effectiveness of ACT on secondary outcome variables of
interest similar ANOVA procedures were conducted; one-way repeated measures
ANOVAs were implemented to determine if general wellbeing (WHO-5), depression
(PHQ-9), moral injury (MIES) and shame (ISS) significantly changed over the course of
treatment and follow-up. Means and standard deviations were presented in Table 7.
For general wellbeing (WHO-5), results on a one-way ANOVA yielded
significant effects by time, F(1.64, 51.97) = 23.34, p < .001, partial η2 = .42. The
Mauchly’s test of sphericity indicated that the assumptions of sphericity had been
violated, X2 (2) = 10.20, p = .017, therefore degrees of freedom were corrected by
reporting the Greenhouse-Geisser estimates for the WHO-5. Post hoc test of multiple
comparisons, using the Sidak corrections, indicated that general well-being significantly
increased from pretreatment (M = 9.60, SD = 4.34) to posttreatment (M = 13.07, SD =
4.60) (p < .001), however pretreatment scores did not significantly differ from follow-up
scores (p = .67). Results showed a large effect size from pretreatment to posttreatment,
Cohen’s d = 0.77. General wellbeing decreased from posttreatment (M =13.07, SD =
4.60) to follow-up (M = 8.74, SD = 5.01). As predicted, wellbeing significantly improved
pre- to posttreatment, however gains were not maintained at follow-up.
For shame (ISS), results on a one-way repeated measures ANOVA yielded no
significant effect by time, F(1.60, 50) = .71, p = .46, partial η2 = .022. Of note, the
Mauchly’s test of sphericity indicated that the assumptions of sphericity had been
violated, X2 (2) = 8.16, p = .006 therefore degrees of freedom were corrected by reporting
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the Greenhouse-Geisser estimates for the ISS.
For depression (PHQ-9), results on a one-way repeated measures ANOVA
yielded significant effects by time F(2, 64) = .731, p = .003, partial η2 = .188. The
Mauchly’s test indicated that the assumptions of sphericity had been violated, X2 (2) =
10.27, p = .006 therefore degrees of freedom were corrected by reporting the
Greenhouse-Geisser estimates for the PHQ-9. Post hoc test of multiple comparisons,
using the Sidak corrections, indicated that depression significantly decreased from
pretreatment (M = 13.03, SD = 5.82) to posttreatment (M = 11.38, SD = 5.24, p = .024),
however pretreatment scores did not show a significant difference from follow-up scores
(p = .25). Results showed a small to medium effect size from pre- to posttreatment,
Cohen’s d = 0.30. Inconsistent with predictions, depression appeared to (significantly)
increase from posttreatment to follow-up (p = .006).
For moral injury events by perceived transgressions (MIES), a one-way ANOVA
yielded significant differences by time, F(2,64) = 20.40, p < .001, partial η2 = .40. Post
hoc test of multiple comparisons, using the Sidak corrections, indicated that perceived
transgressions of moral injury, significantly decreased from pretreatment (M = 17.23, SD
= 6.27) to posttreatment (M = 14.86, SD = 6.77, p = .033). Contrary to predictions, scores
significantly increased from pretreatment (M = 17.23, SD = 6.27) to follow-up (M =
19.77, SD = 6.63, p = .006). Taken together, the number of perceived moral injury events
by transgressions significantly decreased pre-to posttreatment; however, contrary to
predictions, the number of perceived moral injury events by transgression increased from
pretreatment to follow-up.
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For moral injury events by perceived betrayals (MIES), a one-way ANOVA
yielded significant differences by time, F(2,64) = 7.08, p =.002, partial η2 = .18. Post hoc
test of multiple comparisons, using the Sidak corrections, indicated that the number of
reported moral injury events by perceived betrayals, did not significantly decrease from
pretreatment treatment (M = 7.94, SD = 2.76) to posttreatment (M = 8.10, SD = 2.50, p
=.94). Contrary to predictions, the number of reported moral injury events by perceived
betrayals significantly increased from pretreatment (M = 7.94, SD = 2.76) to follow-up
(M = 9.33, SD = 4.10, p = .006). Taken together, the number of perceived betrayals on
the moral injury events scale did not significantly improve pre- to posttreatment and
follow-up.

Process of Change Measures
With respect to process measures, participants completed measures of
psychological flexibility and valued living at pretreatment, mid-point 1 (session three),
mid-point 2 (session six), posttreatment and follow-up. One-way repeated measures
ANOVAs were implemented to determine if process of change measures (AAQ-II, VQ,
BAFT) progressed in the predicted direction from pretreatment to posttreatment to
follow-up. Table 8 includes the means and stand deviations.
Results showed a nearly significant effect of time on psychological flexibility F(2,
64) = 3.08, p = .053, partial η2 = .088. Post hoc test of multiple comparisons, using the
Sidak corrections, indicated that changes in psychological flexibility from pretreatment to
posttreatment were nonsignificant (p = .663) and were nonsignificant from pretreatment
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Table 8
Process Measures Means and Standard Deviations from Pretreatment, Posttreatment,
and Follow-Up
Pretreatment
(n = 33)
─────────
Variable

Session 3
(n = 33)
─────────

Session 6
(n = 33)
─────────

Posttreatment
(n = 33)
─────────

Follow- Up
(n = 33)
─────────

M

SD

M

SD

M

SD

M

SD

M

SD

31.97

10.21

31.46

8.75

31.72

8.10

30.81

9.30

33.80

8.10

-

-

-

-

Negative
evaluation

28.33

9.10

-

-

-

-

27.81

7.53

30.20

5.80

Somatic concerns

19.84

7.30

-

-

-

-

16.24

6.30

20.72

6.22

Emotion
regulation

25.72

7.20

-

-

-

-

22.41

6.40

24.62

5.74

17.36

5.40

17.50

6.22

18.03

4.82

14.42

6.20

16.10

6.10

Psychological
Flexibility
(AAQ-II)
Defusion (BAFT)

Valued living
(VQ)
Obstruction

Progress
15.70
5.74
17.33
5.43
18.21
5.50
16.91
2.85
19.90
4.00
Note. AAQ-II= Acceptance and Action Questionnaire, BAFT = Believability of Anxious Thoughts and Feelings, VQ=
Valuing Questionnaire.

to follow-up (p = .46). Of note, results showed that psychological flexibility significantly
decreased posttreatment to follow-up (p = .045).
On a one-way repeated measures ANOVA, results showed a trend towards a
significant effect of time on obstruction to Valued Living, F(2, 64) = 2.96, p = .06, partial
η2 = .085. Post hoc test of multiple comparisons, using the Sidak corrections, indicated
that obstruction in valued living significantly decreased pretreatment (M = 17.36, SD =
5.39) to posttreatment (M = 14.23, SD = 6.20, p = .018). However, results showed that
obstruction to valued living did not significantly improve from pretreatment to follow-up
(p = .70). As predicted, obstruction to Valued Living trended towards a significant
decrease from pre- to posttreatment; however, obstruction to valued living did not
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significantly change from pretreatment to follow-up.
Results showed a significant effect of time on progress in Valued Living F(1.65,
52.80) = 9.05, p = .001, partial η2 = .220. The Mauchly’s test of sphericity indicated that
the assumptions of sphericity had been violated, X2 (2) = 7.40, p = .025, therefore
Greenhouse-Geisser estimates were reported for progress in Valued Living. Post hoc test
of multiple comparisons, using the Sidak corrections, indicated that progress in Valued
Living did not significantly improve from pretreatment (M = 15.70, SD = 5.74) to
posttreatment (M = 16.91, SD = 2.85, p = .64), however pretreatment scores (M = 15.70,
SD = 5.74) significantly differed from follow-up scores (M = 19.90, SD = 4.00, p = .002).
As predicted, progress in Valued Living significantly improved from pretreatment to
follow-up.
Results showed a significant effect of time on somatic concerns on the BAFT,
F(2, 64) = 12.11, p < .001, partial η2 = .275. Post hoc test of multiple comparisons, using
the Sidak corrections, indicated that somatic concerns on the BAFT significantly
decreased from pretreatment (M = 19.84, SD = 7.30) to posttreatment (M = 16.24, SD =
6.30, p = .002). However, results showed that somatic concerns on the BAFT did not
significantly improve from pretreatment to follow-up (p = .73). As predicted, fusion with
anxious thoughts and feelings related to somatic concerns decreased pre- to
posttreatment, however improvements did not maintain at follow-up.
Results showed a significant effect of time on emotion regulation on the BAFT,
F(2, 64) = 6.25, p = .003, partial η2 = .163. Post hoc test of multiple comparisons, using
the Sidak corrections, indicated that emotion regulation on the BAFT significantly
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decreased from pretreatment (M = 25.72, SD = 7.20) to posttreatment (M = 22.41, SD =
6.40, p = .017). However, results showed that emotion regulation on the BAFT did not
significantly improve pretreatment to follow-up (p = .46). As predicted, fusion with
anxious thoughts and feelings related to emotion regulation improved pretreatment to
posttreatment, however improvements did not maintain at follow-up.
Results showed a significant effect of time on negative evaluation on the BAFT,
F(1.62, 52.54) = 4.40, p = .024, partial η2 = .120. The Mauchly’s test of sphericity
indicated that the assumptions of sphericity had been violated, X2 (2) = 7.63 p = .022, thus
Greenhouse-Geisser estimates were reported. Post hoc test of multiple comparisons,
using the Sidak corrections, indicated that negative evaluation on the BAFT, did not
significantly improve from pretreatment to posttreatment (p = .90), nor from pretreatment
to follow-up (p = .22). However, results showed that negative evaluation on the BAFT
significantly increased from posttreatment to follow-up (p = .005). Contrary to
predictions, fusion with anxious thoughts and feelings related to negative evaluations did
not improve over the course of treatment and appeared to worsen from posttreatment to
follow-up.

Secondary Outcomes
Research Question 2a. Do pretreatment levels depression, shame, moral injury
and well-being predict response to treatment?
Research Question 2b. Do pretreatment levels of psychological inflexibility and
cognitive fusion predict response to treatment?
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Prior to regression analyses, we examined the relationship between depression,
moral injury, shame, wellbeing and the primary outcome variables of interest including
PTSD diagnostic status, PTSD symptoms, valued living, and quality of life. Pearson R
correlations were used to determine the association between variables. Table 9 presents
correlations between pretreatment measures and primary outcome variables.
As shown in Table 9, veterans with a PTSD diagnosis showed a strong positive
correlation with PTSD symptoms (PCL-5), r = .66, p < .01 and a strong positive
correlation with shame (ISS), r = .37, p < .05. PTSD diagnostic status showed a negative
relationship with quality of life (QOL) r = -.45 p < .01 and progress in valued living r = .36, p < .01. As expected, PTSD symptoms at pretreatment (PCL-5) showed a strong
negative correlation with quality of life (QOL), r = -.71, p < .01; progress in valued living
(VQ-progress), r = -.54, p < .01 and overall well-being (WHO-5), r = -.64, p < .01.
Results showed a strong positive correlation between PTSD symptoms (PCL-5) and
obstruction in valued living (VQ-obstruction) r = .71, p < .01, shame (ISS), r = .58, p <
.01 and depression (PHQ-9) r = .72 p < .01. Furthermore, findings show strong negative
correlations between quality of life (QOLS) and obstruction to valued living (VQobstruction), r = -.57, p < .01, shame (ISS) r = -.60, p < .01, and depression (PHQ-9), r
= -.77, p < .01. There were strong positive correlations between quality of life (QOL) and
progress in valued living (VQ-progress), r = .64, p < .01 and overall well-being (WHO5), r = .722, p < .01. As expected, results showed a strong negative correlation between
obstruction in valued living (VQ-obstruction) and progress in valued living (VQprogress), r = -.36, p < .05 and obstruction in valued living (VQ-obstruction) and overall
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Table 9
Bivariate Correlations Among Predictor and Primary Outcome Variables Pretreatment
Variables

1

1.PCL-5 dx

-

2.PCL-5

.66**

3.QOLS

-.45**

4.VQ-obstruction

2

3

4

5

6

7

8

-.71**

.07

-

-

.17

.71**

-.57**

-.54**

.64**

-.36*

.37*

.58**

-.60**

.56**

-.66**

-

7 PHQ-9

.44*

.72**

-.77**

.55**

-.72**

.62**

-

8. MIES-betrayal

-.30

-.15

.06

.04

.18

-.26

-.29

9. MIES-transgression

-.28

-.26

.18

-.12

.28

-.33

-.21

.25

10. WHO-5

-.24

-.64**

.72**

-.67**

.42*

-.29

-.73**

.04

6. ISS

10

-

-.36*

5. VQ-progress

9

-

-

Note. PCL-5 dx = PTSD diagnostic status; PCL-5 = PTSD checklist; QOLS = Quality of Life Scale; VQobstruction/progress = Valuing Questionnaire; ISS = Internalized Shame Scale; PHQ-9 = Patient-Health
Questionnaire; MIES = Moral Injury Event Scale; WHO-5 = World Health Organization Well Being Index.
* p < .05.
**p < .01.

wellbeing (WHO-5), r = -.67, p < .01. Results showed that obstruction in valued living
(VQ-obstruction) had a strong positive correlation with shame (ISS) r = .56, p < .01 and
depression (PHQ-9), r = .55, p < .01. Additionally, progress in valued living (VQprogress) showed a strong negative correlation with shame (ISS), r = -.66, p < .01 and
depression (PHQ-9), r = -.72, p < .01 and a positive correlation with well-being (WHO5), r = .42, p < .05. Shame (ISS) and depression (PHQ-9) showed a strong positive
correlation r = .622, p < .01. Of note, moral injury showed no significant correlations
with any pretreatment measures.
2a. Do pretreatment levels depression, shame, moral injury, well-being predict
response to treatment?
Binomial logistic regression analyses were conducted in SPSS version 23.0, to
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determine if pretreatment symptoms significantly predicted response to treatment, as
measured by a 5-point change on the PCL-5. Specifically, we aimed to predict the
probability that a veteran showed a response to treatment based on pretreatment symptom
scores.
In order to determine covariates for the model, a series of regression analyses
were conducted with blocks of demographic variables (e.g., age, educational, marital
status, race/ethnicity, religion, PTSD dx) and military characteristics (e.g., years in
service, branch, era, number of deployments, previous PTSD treatment). Results found
branch of military service to be a significant predictor of PTSD change from pretreatment
to posttreatment; however, once placed in the model with other variables branch of
military service was nonsignificant and, therefore, excluded from the model.
Furthermore, all other demographic variables were nonsignificant and were excluded
from the model.
To assure that all appropriate assumptions were met for the logistic regression
model several procedures were conducted. First, to assess for linearity between the
continuous variables and the logit of the dependent variable, Box-Tidwell (1962)
procedures were followed. Results showed that each of the predictor variables were
linearly related to the logit of the dependent variable (PCL-5 change). Second, to assess
for multicollinearity, Tolerance/VIF statistics were examined. VIF scores of ten or
greater were used to indicate serious multicollinearity (Cohen, Cohen, West, & Aiken,
2013). Some mulitcollinearity was detected between the PHQ-9 and the MIES
transgression (VIF = 3.71) and the PHQ-9 and MIES betrayal (VIF = 3.6). Third, to
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assess for significant outliers, residuals were assessed. Results showed that there was one
studentized residual on the depression variable (PHQ-9) = -3.04, which remained in the
analyses.
Next, a series of simple logistic regressions were conducted to assess the whether
pretreatment depression, shame, moral injury and well-being predicted the likelihood that
a veteran showed a positive response to treatment. All results are presented in Table 10.
Contrary to predictions, results showed that pretreatment levels of depression, shame,
well-being, and moral injury due to perceived betrayals did not significantly predict a
response to treatment as measured by a 5-point change in PTSD symptoms pre- to
posttreatment. Results showed that pretreatment levels of moral injury by perceived
transgressions was significant in predicting a response to treatment (5-point change on
Table 10
Logistic Regression Predicting Likelihood in PTSD Treatment Response Based on
Pretreatment Symptoms
SE

Wald

df

p

Odds
ratio

95% CI
Lower

95% CI
Lower

.11

.078

2.08

1

.15

1.12

.96

1.30

.02

.018

1.11

1

.29

1.02

.98

1.06

WHO-5

-.11

.092

1.53

1

.22

.89

.75

1.07

MIES-B

-.11

.155

0.90

1

.34

.90

.72

1.12

MIES-T

-.11

.053

4.26

1

.04

.90

.81

.99

AAQ-II

.06

.039

2.11

1

.15

1.06

.98

1.14

BAFT er

.05

.090

0.35

1

.56

1.05

.88

1.26

BAFT sm

.12

1.16

1

.28

1.13

.91

1.4

Variables

B

PHQ-9
ISS

0.11

BAFT ne
-.09
0.10
0.85
1
.36
.91
.75
1.11
Note. PHQ-9 = Patient-Health Questionnaire; ISS = Internalized Shame Scale; WHO-5 = World Health
Organization Well Being Index, MIES = Moral Injury Event Scale; MIES-B = Moral Injury Events Scale
Betrayals; MIES-T = Moral Injury Events Scale Transgressions; AAQ-II = Acceptance and Action
Questionnaire, BAFT = Believability of Anxious Thoughts and Feelings, er = emotion regulation, sm =
somatic concerns, ne = negative evaluation.
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the PCL-5) from pre- to posttreatment. The logistic regression model was statistically
significant X2 (1) = 4.96, p = .026 and correctly classified 69.7% of the participants. In
this model, moral injury measured by perceived transgressions explained 19.4%
(Nagelkerke R square) of the variance. Furthermore, increasing the number of reported
moral injuries by perceived transgressions was associated with a reduction in the
likelihood of showing a statistically significant response to treatment. Specifically, a oneunit change in moral injury by perceived transgressions decreased the log odds by .88.
2b. Do pretreatment levels of psychological inflexibility and cognitive fusion
predict response to treatment?
Additional logistic regressions were conducted to predict response to treatment
based on pretreatment levels of psychological inflexibility (AAQ-II) and cognitive fusion
(BAFT). Again tests of assumptions were conducted to assess for linearity,
multicollinearity, and significant outliers. A bonferroni correction was made for all the
independent variables and the interaction terms, which suggested that p < .0065
represented statistical significance (Tabachnick & Fidell, 2007). Tests of assumptions
showed that all independent variables were found to be linearly related the logit of the
dependent variable. Of note, moderate mulitcollinearity existed between the AAQ-II and
the BAFT somatic concerns (VIF = 3.86) and the AAQ-II and BAFT negative effect
(VIF = 5.43). As one might expect, multicollinearity existed between the BAFT
subscales; specifically, the BAFT somatic concerns and BAFT negative evaluation (VIF
= 4.23) and BAFT emotion regulation and BAFT somatic concerns (VIF = 3.89) and
BAFT somatic concerns and BAFT negative evaluation (VIF = 5.22). Finally, test of

65
assumptions revealed one studentized residual on the BAFT variable -2.5, which
remained in the analyses.
Results showed that pretreatment levels of psychological inflexibility (AAQ-II)
did not significantly predict a response to treatment as measured by a 5-point change in
PTSD symptoms pretreatment to posttreatment. Further, results from the logistic
regression found that cognitive fusion at pretreatment did not significantly predict a
response to treatment. Contrary to predictions, greater psychological inflexibility and
higher cognitive fusion at pretreatment was not predictive of response to treatment.
Research Question 3: Do changes in psychological flexibility (AAQ-II) and
Valued Living (VQ) predict PTSD symptom severity posttreatment?
In order to assess whether changes in treatment processes predicted changes in
outcomes, above baseline functioning, bivariate correlation analyses were conducted.
First, change scores were calculated (AAQ pretreatment - AAQ session 6) and (VQ
pretreatment- VQ session 6). Next, a bivariate correlation was conducted to assess the
relationship between changes in psychological flexibility (AAQ change) and PTSD
posttreatment (PCL-5). Preliminary analyses showed the relationship to be monotonic,
which was assessed through visual inspection of a scatterplot of the two variables.
Results showed that there was a weak positive correlation between changes in
psychological flexibility and PTSD symptom severity at posttreatment, rs (31) = .284, p =
0.11. Contrary to predictions, change in psychological flexibility over the course of
treatment was not significantly associated with PTSD posttreatment.
Another Spearman’s rank-order correlation was conducted to assess the
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relationship between changes in valued living and PTSD symptoms posttreatment. Again,
preliminary analyses showed the relationship to be monotonic, which was assessed
through visual inspection of a scatterplot of the two variables. Results showed that there
was a weak negative correlation between changes in progress towards Valued Living and
PTSD symptom severity at posttreatment, rs (31) = -.23, p = 0.19. Contrary to
predictions, a change in valued living over the course of treatment was not significantly
associated with PTSD symptoms posttreatment. Results showed that there was a weak
positive correlation between changes in obstruction to Valued Living subscales and
PTSD symptom severity posttreatment, rs (31) = .11, p = 0.55.
Research Question 4: How acceptable is ACT as an intervention for veterans
diagnosed with PTSD?
To assess treatment acceptability scores on the TEI-SF were evaluated from both
posttreatment and follow-up assessments. As predicted, results showed that a majority of
veterans who completed treatment 97% (n = 18), found the ACT intervention to be highly
acceptable (a score > 21). Scores range from 0 to 35 with higher scores indicating greater
acceptability (M = 28.26, SD = 3.20) and follow-up (M = 28.00, SD = 3.91).
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CHAPTER V
DISCUSSION

Primary Outcomes
The present study examined the effectiveness of an ACT intervention for veterans
with PTSD and subclinical PTSD who had previously completed a gold standard
treatment for PTSD (n = 33). An 8-week closed group design was used, which
implemented a protocol focused on increasing valued living and decreasing experiential
avoidance. The main outcomes of interest were changes in PTSD symptoms, valued
living, and quality of life from pre- to posttreatment, and again at 1-month follow-up.
Results showed that 64.7% of veterans showed a favorable response to treatment
as measured by a 5-point change in PTSD symptoms. Further analyses found that 35.3%
of veterans showed a clinically meaningful change (10-point change on PCL-5) over the
course of treatment and 25.3% of veterans showed a reliable change utilizing the reliable
change index. Results suggest that a majority of the veterans—with PTSD or
subthreshold PTSD- experienced a positive response to treatment. Perhaps, the lack of
clinically meaningful change among some of the study sample can be associated with the
chronic nature of their PTSD. Additionally, the lack of reliable change for many on the
major outcome of interest (PCL-5) may be attributed to the stringent nature of the reliable
change index (Benotsch et al., 2000; Loerinc et al., 2015).
Overall, findings from this study on primary outcomes of interest were mixed.
Primary outcomes included PTSD symptoms, quality of life, and valued living. As
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hypothesized, results showed that PTSD symptoms (PCL-5) significantly decreased from
pre- to posttreatment, although no significant difference was found at the one-month
follow-up assessment. These findings are consistent with previous literature suggesting
that up to two-thirds of veterans completing the gold standard treatments for PTSD, retain
their diagnosis posttreatment, mean scores remain at or above the clinical cutoff, and full
remission is rare (Steenkamp et al., 2015).
The VQ consists of subscales measuring progress and obstructions towards
valued living. In line with predictions, veterans showed a significant improvement in
progress towards valued living from pre- to follow-up. Results showed that veterans
showed a trend towards a significant reduction in obstructions to valued living from preto posttreatment. However, obstructions towards valued living did not improve
pretreatment to follow-up. It is possible that weekly check-ins regarding behavioral
commitments, highlighted a veteran’s progress and barriers towards valued living.
Perhaps, this weekly exercise enhanced a veteran’s awareness of moving towards a
valued life, while simultaneously increasing a veteran’s sensitivity to barriers or
obstructions that impede progress towards valued living.
The QOLS broadly measures life satisfaction at the time of assessment. Contrary
to predictions, quality of life did not significantly increase from pre- to posttreatment.
Furthermore, results showed a significant decrease in quality of life from pretreatment to
follow-up. One possible explanation is that improvement in quality of life may require
more than 8 to 12 weeks to observe in veterans with chronic PTSD/subthreshold PTSD.
Another possibility is that veterans with PTSD may consider all life experiences
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including military deployments and trauma exposure, when responding to questions on
overall life satisfaction.
Results on secondary outcome variables of interest provided additional
information on the effectiveness of an ACT group for veterans with PTSD/subthreshold
PTSD. The secondary outcome variables of interest were measures of depression (PHQ9), moral injury (MIES), shame (ISS), and general wellbeing (WHO-5). Consistent with
predictions, veterans showed significant improvements from pre- to posttreatment on
overall wellbeing and depression; however, gains did not maintain at follow-up. Research
suggests that active participation in a group intervention may provide social support and
eliminate avoidant behaviors (e.g., Sripada et al., 2016). Perhaps, weekly group
attendance improved a veteran’s social support network, decreased avoidant behaviors,
and ultimately alleviated depressive symptoms. However, it is also possible that veterans
experienced the opposite upon group termination. As a result, veterans may have returned
to avoidant behavior patterns that once contributed to baseline depression and poor
general wellbeing.
Contrary to predictions, results showed no significant difference in shame
symptoms (ISS) from pre- to posttreatment and follow-up. One explanation is that the
content and experiential exercises of the intervention did not accurately target the
construct of shame. Research suggests that treatment of shame is most effective when the
construct is targeted directly (J. B. Luoma, Kohlenberg, Hayes, Bunting, & Rye, 2008).
The moral injury event scale measured the number of moral injury events (MIEs)
experienced by a veteran. The MIES consists of two subscales, one that measures moral
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injurious events that are associated with perceived betrayals and one that measures moral
injurious events that are associated with perceived transgressions. Consistent with our
prediction, the number of perceived transgressions significantly decreased from pre- to
posttreatment. However, results showed that perceived transgressions increased from
pretreatment to follow-up. Interestingly the number of perceived betrayals did not
significantly decrease over the course of treatment. One possible explanation is that the
MIES assesses the number of events experienced rather than assessing the quality or
content of the events. From a theoretical perspective, one might expect ACT to improve
acceptance of MIEs, but not necessarily alter the number of reported MIEs.
Additionally, we examined process of change measures including the AAQ-II and
the BAFT. Results showed that psychological flexibility did not significantly improve
over the course of treatment, and decreased from posttreatment to follow-up. One
explanation is that an eight-week intervention was insufficient at producing lasting
change on the measure of psychological flexibility. Yet, another explanation is that the
AAQ-II has had some difficulty detecting change in clinical outcome research, as this
version of the measure uses broad language that may not be specific enough to capture
psychological flexibility related to posttraumatic stress (e.g., J. Luoma, Drake,
Kohlenberg, & Hayes, 2011).
The BAFT consists of three subscales, measuring cognitive fusion with somatic
concerns, emotion regulation, and negative evaluation. Consistent with predictions,
cognitive fusion related to somatic concerns and emotion regulation significantly
decreased over the course of treatment, however gains were not maintained at follow-up.
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Of note, cognitive fusion related to negative evaluation did not significantly improve and
appeared to increase from posttreatment to follow-up. Perhaps, the treatment protocol
included experiential exercises that emphasized an acceptance of internal experiences
associated with somatic and emotional concerns more so than negative evaluation.
However, this is unlikely given that two sessions were devoted to cognitive defusion
exercises.
Taken together, these results suggest that an eight-week ACT group intervention
was effective at reducing PTSD symptoms, increasing progress towards valued living,
decreasing depression and increasing wellbeing. Specifically, this treatment produced
small to moderate effect sizes, good clinical effectiveness pre- to posttreatment however,
treatment gains at follow-up were poor.

Secondary Outcomes
In addition to the primary and secondary analyses of interest, we were interested
in whether pretreatment levels of depression, shame, moral injury and wellbeing would
predict response to treatment. Contrary to predictions, results showed that levels of
depression, shame, and wellbeing at pretreatment did not significantly predict a response
to treatment. These findings are inconsistent with a previous research study, which found
moderate to severe depression at pretreatment to predict a greater reduction in symptoms
posttreatment. However, the same study showed that individuals with higher symptom
severity at baseline continued to experience significant symptoms posttreatment
(Felleman, Stewart, Simpson, Heppner, & Kearney, 2016). An alternative explanation for
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null findings could be the small sample size used in the logistic regression analyses.
Some researchers suggest a minimum of 50 cases in order to conduct logistic regression,
while others suggesting a bare minimum of 15 cases (Peng, Lee, & Ingersoll, 2002).
Interestingly, results showed that the number of moral injury event (MIEs) due to
perceived transgressions was a significant predictor for response to treatment.
Specifically, the greater number of reported MIEs by transgression- the less likely a
veteran would show a response to treatment. Perhaps, the number of MIEs experienced
by a veteran is a maintaining factor for chronic PTSD. These findings are consistent with
a recent study showing that veterans with refractory PTSD are more likely to recall MIEs
that are internal rather than external. Furthermore, veterans in the study often expressed
guilt and shame associated with actions they performed or participated in during
deployment (Currier, McCormick, et al., 2015). Of note, moral injury by perceived
betrayals was not a significant predictor of response to treatment. It is possible that a
sense of betrayal by a leader is not a maintaining factor for PTSD. However, malpractice
or betrayal from leadership is a vastly under-researched topic in the literature (Currier,
McCormick, et al., 2015)
Additional analyses examined whether pretreatment levels of psychological
flexibility and cognitive fusion predicted a response to treatment. Contrary to predictions,
neither pretreatment levels of psychological flexibility/experiential avoidance nor
cognitive fusion predicted response to treatment. These findings are surprising
considering the abundance of research that suggests greater experiential avoidance and
cognitive fusion are related to posttraumatic stress symptoms (e.g., Benotsch et al., 2000;
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Plumb et al., 2004; Tull et al., 2004).

Process of Change
To examine whether ACT theorized process of change measures were associated
with posttreatment symptom severity. To do so, change scores were calculated between
pretreatment psychological flexibility ratings (AAQ-II) and session six psychological
flexibility ratings (AAQ-II). Change scores were also calculated between pretreatment
ratings of valued living (VQ) and session six ratings of valued living (VQ). Results
showed that changes in psychological flexibility over the course of treatment
(pretreatment AAQ-II scores—session six AAQ-II scores) were not significantly
associated with PTSD symptom severity at posttreatment. These findings are surprising,
given that the AAQ-II is a measure of psychological flexibility, the purported mechanism
of change in ACT (Hayes et al., 2006). Perhaps, a change score over the course of six
weeks was an insufficient amount of time to shift the broader construct of psychological
flexibility. Further, contrary to predictions, results showed that changes in progress
towards valued living and obstruction towards valued living, were not significantly
associated with PTSD symptom severity posttreatment. It is possible that progress
towards valued living, occurred regardless of the presence of PTSD symptoms, which
may be expected from an ACT treatment model. An alternative explanation is that the
VQ functions better as an outcome measure, rather than a process measure.

Summary of Acceptability Outcomes
In addition to our primary outcomes, we were interested in whether or not ACT
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would be an acceptable treatment for veterans with PTSD. As predicted, veterans who
attended the group found it to be highly acceptable. It is important to note that a notable
number of veterans did not fully complete the 8-week intervention. It is possible that drop
out provides information regarding the acceptability of the treatment. Veterans may have
found the group less acceptable or inconsistent with their expectations for treatment,
ultimately resulting in dropout. Future studies may consider providing a more thorough
explanation of the treatment prior to the initial session. It may also be important to
explain to group participants that ACT utilizes experiential exercises and encourages
active group participation, which may not be an appealing treatment approach for
veterans with refractory PTSD.

Empirical Implications
Results from this study provide empirical support for ACT as a second-line
intervention for PTSD. While data is limited, four case studies and one multiple baseline
study found ACT to be an effective treatment for PTSD and comorbid disorders (Batten
& Hayes, 2005; Burrows, 2013; Orsillo & Batten, 2005; Twohig, 2009a; Woidneck et al.,
2013). Moreover, this is the first known study to examine the effectiveness of an ACT
group for veterans who have completed a first line treatment for PTSD (CPT, PE,
EMDR), yet continue to experience PTSD/subthreshold PTSD. Results found ACT to be
an effective intervention for improving PTSD symptoms and increasing valued living in
veterans with refractory PTSD. Despite these gains, we reported that a majority of
veterans in our study remained above the clinical cutoff for meaningful change. These
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findings are consistent with previous research suggesting that nearly one-third to one-half
of veterans who receive exposure-based therapies do not respond to treatment at the level
that is expected (Schottenbauer et al., 2008; Steenkamp et al., 2015). Overall, this study
provides evidence for ACT as an intervention for PTSD, however, the long-term
effectiveness appears limited or in need of further attention.
Despite the existing data for effective PTSD treatments, research shows that
treatment gains are not always maintained at follow-up. For example, a recent study
offered an extensive and critical review regarding the efficacy of first-line
psychotherapies for veterans and military personal with PTSD. Results showed that CPT
and PE outperformed treatment-as-usual and waitlist controls, however, only 49-70% of
individuals showed a clinically meaningful change (10- to 12-point change on PTSD
symptoms). Furthermore, results showed that PTSD scores at posttreatment remained at
or above the clinical cutoff for PTSD and nearly two-thirds of the military
personal/veterans retained their PTSD diagnosis posttreatment (Steenkamp et al., 2015).
Therefore, our study results at follow-up are within the existing ranges presented in the
literature and may be expected. Furthermore, findings from this study further illuminate
the need for continued resources and therapeutic options for veterans following the
completion of a trauma-focused therapy.
One such option is to provide veterans the opportunity to attend a non-trauma
focused psychotherapy group. Evidence indicates that group psychotherapy provides
social support, while providing an opportunity to practice exposure to social contexts
(Ready et al., 2012; Sripada et al., 2016). Therefore, attending group therapy may directly
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target experiential avoidance and provide corrective learning experiences for veterans
with PTSD. From an ACT perspective, PTSD is often maintained by behavioral
avoidance or experiential avoidance (Thompson & Waltz, 2010). Thus, offering a group
that emphasizes acceptance may be more effective than a group than emphasizes fear
reduction.
This study contributes to the ongoing debate on whether tolerance or fear
reduction is a more effective model for the treatment of PTSD (Bluett, Zoellner & Feeny,
2013). Research suggests that promoting tolerance in the presence of fear or distress
creates more robust learning (inhibitory learning; Craske et al., 2008). Moreover, the
ACT treatment model aims to move beyond tolerance to acceptance to further increase
inhibitory learning (Thompson et al., 2013). The ACT treatment model promotes
exposure as a way to practice acceptance in the presence of distress- with the purpose of
living a more meaningful life (Eifert & Forsyth, 2005). Overall, findings from this study
suggest that a mindfulness and acceptance-based intervention increases ones’ progress
towards valued living. Additionally, anecdotal evidence regarding the success of weekly
behavioral commitments, suggests that veterans were utilizing acceptance strategies in
previously avoided contexts, in order to move towards personal values.
There is a growing body of research aiming to understand, define and treat moral
injury. For example, a recent study interviewed fourteen male veterans/military personal
in efforts to clarify the contextual factors that may lead to or be perceived as a moral
injury event (MIE). Similar to our study sample- all fourteen participants had received
outpatient treatment for PTSD, failed to improve, and were completing intensive
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residential treatment for PTSD. Interestingly, the veterans and military personal reported
psychological experiences or internal experiences as being a greater factor in determining
moral injury compared to organizational, cultural, and environmental experiences
(Currier, McCormick, et al., 2015). Our study compliments these findings, by providing
quantitative data regarding the number of moral injury events and type of MIEs
experienced by veterans with PTSD.
Recently, attention has been directed to understanding the interplay between
posttraumatic stress and moral injury. The role of shame was examined in this study, as it
appears to be a maintaining factor for both moral injury (A Nieuwsma et al., 2015) and
PTSD (A Nieuwsma et al., 2015; Currier, Holland, & Malott, 2015; Currier, McCormick,
et al., 2015; Gutierrez & Hagedorn, 2013). As shown in the results, shame did not
improve over the course of treatment. These findings are inconsistent with a large clinical
trial, which found ACT to be an effective intervention for shame (J. B. Luoma,
Kohlenberg, Hayes, & Fletcher, 2012). Moreover, research has shown that interventions
that target shame directly tend to be more effective (J. B. Luoma et al., 2008). One
possible conclusion is that our intervention did not appropriately target the construct of
shame. In conclusion, further research is needed to understand the construct of moral
injury, the relationship to posttraumatic stress, and how underlying factors such as shame
may inhibit long-term recovery.

Clinical Implications
This study offers promising implications for the treatment of PTSD among
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veterans with chronic PTSD. First, this study provides some indication that an ACT
protocol for PTSD can be effective with veterans in a group setting. Second, results
showed significant improvements towards valued living, which provides early
implications that a values-driven protocol is useful for veterans with PTSD. Third, data
from this study contributes to the growing body of literature testing alternative and
complimentary treatments for PTSD. Furthermore, this study supports previous research
indicating that ACT is an effective treatment for depression and improves general
wellbeing.
As previously mentioned, high dropout rates and poor response to treatment is not
uncommon among PTSD treatments. Many veterans who complete a first-line treatment
for PTSD will continue to experience symptoms and dysfunction posttreatment. Of
surprise, many researchers do not report the need for continued care among treatment
completers (Steenkamp et al., 2015). Veterans recruited for this study were quite
obviously in need of treatment above and beyond the prescribed dosage of 10-12 sessions
offered in a trauma-focused treatment protocol. Furthermore, ongoing referrals to the
group, suggest that treatment providers acknowledge that completion of an EBT for
PTSD may not be sufficient for some veterans. In sum, findings from this study would
encourage the Veteran’s Health Care Administration along with mental health providers
to continue to provide and improve upon continued care options, such as group therapy,
for veterans with refractory PTSD.
Extensive research has found group therapy to have strong efficacy, retention, and
patient acceptability in the treatment of PTSD (e.g., Barrera et al., 2013; Sloan et al.,
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2013). Consistent with existing literature, veterans in this study found the eight-week
ACT group to be highly acceptable. It is likely that veterans who have completed a
trauma-focused intervention continue to need guidance in clarifying their values after
trauma as well as learning new strategies to manage residual symptoms. ACT is a natural
fit for chronic PTSD. Taken together, an ACT group may be an excellent next-step
treatment option for veterans who have completed a trauma-focused intervention.
Lastly, this study informs both researchers and clinicians about the pervasive and
potent impact of moral injury events. Findings from this study suggest that a number of
veterans with PTSD report moral injury events. Further, nonsignificant findings suggest
that moral injury may be a difficult construct to shift. Of interest, a recent conceptual
paper by Nieuwsma et al. (2015) suggested that ACT might be applicable in both
conceptualizing and treating moral injury. In brief, the article suggests that “ACT works
with those who have suffered moral injury by assisting them to explore and open up to
the emotional and thought aspects of their injuries, seeing what values were violated, and
reengaging in meaningful ways” (A Nieuwsma et al., 2015). Finally, this study provides
some indication that clinicians should consider moral injury when treating PTSD. While,
no evidence-based treatments exist for moral injury, there has been one preliminary
attempt to develop an appropriate treatment. This study highlights the need for an
intervention that targets moral injury and associated symptoms such as guilt and shame.

Mixed Findings
While results showed significant improvements on PTSD symptoms, depression
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symptoms, and overall wellbeing from pretreatment to post treatment, these gains were
not maintained at follow-up. This might suggest that while an ACT group for refractory
PTSD may lead to positive treatment gains during active treatment, it does not result in
robust changes following treatment termination. On the contrary, veteran’s progress
towards valued living appeared to improve over the course of treatment and maintain
after treatment was terminated. Thus, an 8-week ACT intervention may be effective at
motivating veterans to make behavioral changes that are aligned with their long-term
goals. On the contrary, the length and depth of the intervention may have been
insufficient at targeting the psychological difficulties faced by the veterans in the group.
As shown in the results, contrary to predictions, there were many measures that
did not change over the course of treatment and appeared to worsen from pretreatment to
follow-up. Specifically, a measure of quality of life improved pretreatment but decreased
from pretreatment to follow-up, while a measure of shame did not significantly change
over the course of treatment. Additionally, the primary process of change measure,
psychological flexibility, did not significantly change over the course of treatment and
cognitive defusion appeared to improve on somatic concerns and emotion regulation
during treatment, but did not maintain at follow-up. A similar conclusion may be drawn,
while an ACT group may be helpful in some arenas for veterans during treatment, an
eight-week intervention may not be an appropriate match for the chronicity of the
veterans’ PTSD and associated symptoms.
The results raise several questions regarding the long-term effectiveness of an
ACT group intervention for veterans with refractory PTSD. Findings from this study
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suggest that veterans benefit in some capacity by attending an experiential, acceptancebased intervention following prolonged exposure therapy or cognitive processing therapy.
However, the decline of treatment gains posttreatment suggests that additional, optional
treatments should be made available for veterans with chronic PTSD including booster
sessions, ongoing groups, and monthly support groups that emphasize behavior change
and valued living. It is also important to consider that providing a theoretically distinct
model for treating PTSD might lead to confusion for a veteran who has completed
cognitive processing therapy. Specifically, a veteran may struggle to integrate the
concepts of acceptance and defusion, as they may appear counterintuitive for a veteran
who had previously relied on principles of cognitive restructuring for recovery. In sum,
results from this study highlight the potential of secondary treatment options for veterans
with refractory PTSD; however, the duration, frequency, forum, and method of these
treatments remain an empirical question.

Limitations and Future Directions
While findings from this study are encouraging, it is not without limitations. First,
the study lacked a control group, thus we were unable to compare the efficacy of this
intervention to other treatment groups provided to veterans with PTSD. Because this
study was exploratory no control group was selected, however a wait-list or control group
could be implemented as a next step comparison condition. Second, retention was poor at
both posttreatment and follow-up. However, dropout rates from this study were
comparable to previous studies and the Veterans Health Administration acknowledges
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that treatment retention and dropout remains an issue with veterans with PTSD (Seal et
al., 2010). Third, imputed data was estimated using data from only twelve veterans who
completed follow-up. It is hard to know if these twelve individuals accurately represented
the progress of the entire sample. Taken together, future research should aim to recruit a
large number of veterans given the prevalence of treatment dropout. It is also possible
that providing an online follow-up versus paper-pencil would reduce participant burden
and increase follow-up participation.
Fourth, the study included veterans who met criteria for either PTSD or
subthreshold PTSD. This may be an issue when trying to generalize findings to other
second-line treatments for PTSD. On the contrary, research has shown that a major
limitation in trauma research is the emphasis on the diagnostic category of PTSD, which
does not accurately account for individuals with marked impairment who do not meet
diagnostic criteria (Bryant et al., 2015). Thus, our study sample may be a more accurate
clinical representation of veterans with long-standing PTSD. Notably, the study sample
included veterans from a variety of eras, branches, and rank. The heterogeneity of the
sample may have adversely impacted treatment. For example, one’s chronicity of PTSD,
along with the age gap between some of the group members may have impacted a
veteran’s ability to engage and participate in treatment.
Furthermore, exploring ACT as a treatment for moral injury was one aim of this
study. However, upon piloting a standalone moral injury group—study clinicians
recognized the difficulty in directly targeting a construct that has multiple definitions and
very few validated measures. Therefore, future researchers should first aim to define
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moral injury and understand the boundaries of the construct before creating an
intervention. Furthermore, the MIES, was effective at quantifying the number of moral
injury events, but did not provide information regarding the psychological impact of
MIEs. Fortunately, a new assessment on moral injury for military personal has recently
been developed, Future researchers should utilize the moral injury-questionnaire military
(MIQ-M) in hopes of providing insight into the psychological impact of moral injury
within veterans (Currier, Holland, Drescher, & Foy, 2015).
Lastly, future research and clinical trials need to be implemented in order to
further assess the effectiveness of ACT for PTSD. Larger clinical trials examining ACT
for PTSD have been conducted, however, the data has yet to be published. The
publication of previous research will help future researchers refine and adapt existing
protocols and research methods. Additionally, stepped-models of care for veterans with
PTSD should be explored. Specifically, researchers should examine the longitudinal
effects of providing a second line treatment group following completion of a first line
treatment for PTSD. It is possible that effective treatment for PTSD requires multiple
steps in order to create long-term change.
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Recruitment Letter
Hi All,
We will be starting an Acceptance and Commitment Therapy (ACT) group for PTSD &
Moral Injury. In the effort to provide more options for recovery/posttraumatic growth,
this group will be restricted to those Veterans who are diagnosed with PTSD or
subclinical PTSD resulting from combat or MST. Veterans must be group appropriate
without an axis II diagnosis. This will be a closed group that will last between
approximately 8 sessions and meets on Tuesdays from 2:00pm to 4:00 for 120 minutes
starting on (date). Please also refer to the attached flyer. All Vets need to be referred to
either myself via phone, email, or CPRS.
ACT is part of the third‐wave behavioral therapy and can help veterans gain more
psychological flexibility, increase willingness to experience their internal experiences
(i.e., thoughts, emotions, sensations), explore values, and live more consistently with
their values. ACT uses mindfulness and acceptance strategies to accomplish these goals,
therefore, veterans will be led through mindfulness exercises and taught how to
increase their willingness to experience unwanted events, emotions, and thoughts. This
class is for Veterans who are searching for a more meaningful/purpose driven life and
want to learn when and how to apply both aspects of change and acceptance.
When: Tuesdays 2:00pm to 6:30pm
Where: Otter Creek, Bldg 16
Start date: XXX
For more information and/or to refer a veteran please contact either: Brandon Yabko,
Ph.D. (ext. 2870) or Ellen Bluett
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SESSION #___________

Item No.

ID #: __________

INTERNALIZED SHAME SCALE

1

I felt like I am never quite good enough.

2

I felt somehow left out.

3

I thought that people looked down on me.

4

I scolded myself and put myself down.

5

I felt insecure about others’ opinions of me.

6

Compared to other people, I felt like I somehow never measure up.

7

I saw myself as being very small and insignificant.

8

I felt intensely inadequate and full of self-doubt.

9

I felt as if I am somehow defective as a person, like there is something basically
wrong with me.

10

I compared myself to others and felt I am just not as important.

11

I had an overpowering dread that my faults will be revealed in front of others.

12

I saw myself striving for perfection only to continually fall short.

13

I thought that others are able to see my defects.

14

I felt like I could beat myself over the head with a club when I made a mistake.

15

I wanted to shrink away when I made a mistake.

16

I replayed painful events over and over in my mind until I was overwhelmed.

17

At times I felt like I would break into a thousand pieces.

18

I felt as if I had lost control over my body functions and my feelings.

19

Sometimes I felt no bigger than a pea.

20

At times I felt so exposed that I wished the earth would open up and swallow me.

21

I had this painful gap within me that I was not able to fill.

22

I felt empty and unfulfilled.

23

My loneliness was more like emptiness.

24

I felt like there is something missing.
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PCL-5

SESSION:____________

ID #: __________

Keeping this worst event in mind, read each of the problems below and then
circle one of the numbers to the right to indicate how much you have been
bothered by that problem in the past month.

Not at
all

A little
bit

Moderate

Quite
a bit

Extreme

Repeated, disturbing, and unwanted memories
of the stressful experience?

0

1

2

3

4

Repeated, disturbing dreams of the stressful
experience?

0

1

2

3

4

Suddenly feeling or acting as if the stressful
experience were actually happening again (as
if you were actually back there reliving it)?

0

1

2

3

4

Feeling very upset when something reminded
you of the stressful experience?

0

1

2

3

4

Having strong physical reactions when
something reminded you of the stressful
experience (for example, heart pounding,
trouble breathing, sweating)?

0

1

2

3

4

Avoiding memories, thoughts, or feelings
related to the stressful experience?

0

1

2

3

4

Avoiding external reminders of the stressful
experience (for example, people, places,
conversations, activities, objects, or
situations)?

0

1

2

3

4

Trouble remembering important parts of the
stressful experience?

0

1

2

3

4

Having strong negative beliefs about yourself,
other people, or the world (for example,
having thoughts such as: I am bad, there is
something seriously wrong with me, no one
can be trusted, the world is completely
dangerous)?

0

1

2

3

4

Blaming yourself or someone else for the
stressful experience or what happened after
it?

0

1

2

3

4

Having strong negative feelings such as fear,
horror, anger, guilt, or shame?

0

1

2

3

4
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Not at
all

A little
bit

Moderate

Quite
a bit

Extreme

Loss of interest in activities you used to enjoy?

0

1

2

3

4

Feeling distant or cut off from other people?

0

1

2

3

4

Trouble experiencing positive feelings (for
example, being unable to feel happiness or
have loving feelings for people close to you)?

0

1

2

3

4

Irritable behavior, angry outbursts, or acting
aggressively?

0

1

2

3

4

Taking too many risks or doing things that
could cause you harm?

0

1

2

3

4

Being “superalert” or watchful or on guard?

0

1

2

3

4

Feeling jumpy or easily startled?

0

1

2

3

4

Having difficulty concentrating?

0

1

2

3

4

Trouble falling or staying asleep?

0

1

2

3

4
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SESSION: __________ ID #: ____

WHO (Five) Well-Being Index (1998 version)
Please indicate for each of the five statements which is closest to how you have been
feeling over the last two weeks. Notice that higher numbers mean better well-being.
Over the last two weeks

All of
the time

Most of the
time

More than
half of the
time

Less than
half of the
time

Some of
the time

At no time

1

I have felt cheerful and in
good spirits

5

4

3

2

1

0

2

I have felt calm and
relaxed

5

4

3

2

1

0

3

I have felt active and
vigorous

5

4

3

2

1

0

4

I woke up feeling fresh
and rested

5

4

3

2

1

0

5

My daily life has been
filled with things that
interest me

5

4

3

2

1

0

Example: If you have felt cheerful and in good spirits more than half of the time during
the last two weeks, put a tick in the box with the number 3 in the upper right corner.
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PHQ-9
SESSION:____________

ID #: __________

Over the last two weeks how often have you been bothered by any of the
following problems? Circle one.
1. Little interest or pleasure in doing things



0. Not at all



1. Several Days



2. More than half of the days

2. Feeling down, depressed or hopeless



0. Not at all



1. Several Days



2. More than half of the days

3. Trouble falling or staying asleep or sleeping too much



0. Not at all



1. Several Days



3. Nearly every day



3. Nearly every day













2. More than half of the days

3. Nearly every day

4. Feeling tired or having little energy



0. Not at all



1. Several Days

5. Poor appetite or over eating



0. Not at all



1. Several Days

2. More than half of the days

2. More than half of the days

3. Nearly every day

3. Nearly every day

6. Feeling bad about yourself‐-‐or that you are a failure or have let your family

down



0. Not at all



1. Several Days



2. More than half of the days



3. Nearly every day

7. Trouble concentrating on things such as reading a newspaper or watching

television



0. Not at all



1. Several Days



2. More than half of the days



3. Nearly every day

8. Moving or speaking so slowly that other people have noticed? Or the opposite‐-‐

being so fidgety or restless that you have been moving around a lot more than
usual




0. Not at all

1. Several Days

2. More than half of the days

3. Nearly every day
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9. Thoughts that you would be better off dead or hurting yourself in some way?



0. Not at all



1. Several Days



2. More than half of the days



3. Nearly every day

If you checked off any problems, how difficult have these problems made it for
you to do your work, take care of things at home, or get along with other people?









0. Not difficult at all 1. Somewhat difficult 2. Very difficult 3. Extremely
difficulty
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SESSION #:____________

ID #: __________
VQ

Please read each statement carefully and then circle the number which best
describes how much the statement was for you DURING THE PAST WEEK,
INCLUDING TODAY

1
Not at all true

2

3

4

5

6
Completely true

1. I spent a lot of time thinking about the past or future, rather than being engaged in
activities that mattered to me
2. I was basically on “auto-pilot” most of the time
3. I worked toward my goals even if I didn’t feel motivated to
4. I was proud about how I lived my life
5. I made progress in the areas of my life I care most about
6. Difficult thoughts, feelings, or memories got in the way of what I really wanted to
do
7. I continued to get better at being the kind of person I want to be
8. When things didn’t go according to plan, I gave up easily
9. I felt like I had purpose in life
10. It seemed like I was just “going through the motions” rather than focusing on
what was important to me
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SESSION:____________

ID #: __________
AAQ-II

Below you will find a list of statements. Please rate how true each statement is for you by circling a
number next to it. Use the scale below to make your choice.
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Believability of Anxious Feelings and Thoughts Questionnaire (BAFT)
Imagine the following thoughts occurred to you right now. How valid or
believable would each be to you? Please use the following scale. For each
thought, please circle a number 1 through 7 depending on how believable that
thought is to you.
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QUALITY OF LIFE SCALE (QOL)
Please read each item and circle the number that best describes how satisfied you are at this
time. Please answer each item even if you do not currently participate in an activity or
have a relationship. You can be satisfied or dissatisfied with not doing the activity or
having the relationship.
Delighted

Pleased

Mostly
satisfied

Mostly
Mixed dissatisfied Unhappy Terrible

1.

Material comforts home, food, conveniences,
financial security

7

6

5

4

3

2

1

2.

Health - being physically fit and vigorous

7

6

5

4

3

2

1

3.

Relationships with parents, siblings & other
relatives- communicating, visiting, helping

7

6

5

4

3

2

1

4.

Having and rearing children

7

6

5

4

3

2

1

5.

Close relationships with spouse or significant
other

7

6

5

4

3

2

1

6.

Close friends

7

6

5

4

3

2

1

7.

Helping and encouraging others, volunteering,
giving advice

7

6

5

4

3

2

1

8.

Participating in organizations and
public affairs

7

6

5

4

3

2

1

9.

Learning- attending school, improving
understanding, getting additional knowledge

7

6

5

4

3

2

1

10.

Understanding yourself - knowing your assets
and limitations - knowing what life is about

7

6

5

4

3

2

1

11.

Work - job or in home

7

6

5

4

3

2

1

12.

Expressing yourself creatively

7

6

5

4

3

2

1

13.

Socializing - meeting other people,
doing things, parties, etc.

7

6

5

4

3

2

1

14.

Reading, listening to music, or observing
entertainment

7

6

5

4

3

2

1

15.

Participating in active recreation

7

6

5

4

3

2

1

16.

Independence, doing for yourself

7

6

5

4

3

2

1
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Demographics
Name:________________________ Last 4:_______ Today’s date:__________

SOCIAL HISTORY
Current marital status:

Married Partnered Separated Divorced
Widow(er)ed

Never married 

Number of previous marriages, if applicable:_____
Number of children:

____ Biological children

____ Step children

____ Adopted children

Housing:

In the past 2 months, have you been living in stable housing that you
own, rent, or stay in as part of a household?
No
Yes
Are you worried that in the next 2 months you may NOT have stable
housing that you own, rent, or stay in as part of a household?
No
Yes. Where have you lived for most of the past 2 months?
Apartment/House/Room – no government
subsidy
Apartment/House/Room – with government
subsidy
With friend/family
Motel/Hotel
Short- term institution like hospital, rehab/drug
treatment center
Homeless shelter
Anywhere outside, e.g. street, vehicle,
abandoned building
Other
Would you like to be referred to talk more about
your housing situation?
No
Yes
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EDUCATION
What is the highest level of education you completed?
Level completed:
Year completed:

Grade school
GED
High school diploma
Professional certificate
College without degree
Bachelors degree
Masters/Doctoral degree
What was your GPA in high school?

3-4 (As and Bs)

2-3 (Bs and Cs)

1-2 (Cs and Ds)

0-1 (Ds and Fs)

Please check if you received the following disciplinary actions in
high school:

Suspended

Expelled
Not applicable If
you were suspended or expelled, what was
the
reason?___________________________
Have you ever been: (check all that apply)

Diagnosed with ADHD or ADD
Sent to an alternative school

Diagnosed with a Learning Disorder
Not applicable
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MILITARY HISTORY
Branch of service:

Dates of service:

Air Force
Air Force National Guard
Air Force Reserve
Army
Army Reserve
Army National Guard
Marines
Marine Reserve
Navy
Navy Reserve
Coast Guard
Basic Training location:__________________________
Date:_______________________
Advanced Training location:______________________
Date:_______________________
MOS/Rating/AFSC:_____________
Pri
mary duty in military:_________________
Duty stations and dates:

____________________________________________________________
____________________________________________________________
Combat tour(s):

Dates of tours (Month/Year):

Operation Enduring Freedom
Operation Iraqi Freedom
Desert Storm
Korean War
Vietnam War
World War II
Other:________________
Combat unit(s), if applicable:_________________________________________
Final rank:____ Highest rank: _____
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Disciplinary actions in the military:

None
Court martial
Nonjudicial punishment (Article 15, NJP, Captain’s/Admiral’s mast, Office
hours)
Type of discharge:
Honorable
Dishonorable

General
Bad Conduct

Other than honorable
Entry level separation
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WORK HISTORY
Current job, if applicable:_____________________ Length of
time at job:______
Number of jobs held since active duty: _____ Longest time at
any one job:________
Type of jobs
held:_______________________________________________________
__
Have you ever experienced these work problems?

Fired or terminated from a job
Written up at work
Problems with supervisors or co-workers
Not applicable
LEGAL HISTORY
Please check if the following apply to you:

Charged with crime
Convicted of crime
Other legal problems: _____________









Are you facing current legal charges or other legal concerns?

No
Yes. Please
describe:________________________________________
If you have experienced past legal issues, please describe:
Charges/Convictions
Dates
_____________________________________________________
_____________________________________________________
_____________________________________________________
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HEALTH
What health problems (hospitalization, significant illness/injury) did you
have:

Prior to the military?

During the military?

After the military?
Please list current medication(s):

Reason(s) taken:

On average, how many hours of actual sleep do you get per night?_____
Overall, how is the quality of your sleep?

Very poor Poor Fair Good Very good Excellent
Do you have sleep apnea?

No

Don’t know

Yes. When did it start? __________

Are you currently applying for an increase in service connection?

No

Yes

Are you currently involved in an appeal of a service connection claim?

No

Yes

Do you excessively engage in or have trouble controlling any of the following
behaviors? (check all that apply)
Pre-military
During military
Post-military



Gambling



Spending money



Overworking



Eating



Sexual activity



Pornography



Driving recklessly



Thrill-seeking



Other dangerous activities
SUBSTANCE HISTORY
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Have you ever smoked or used tobacco in any form?

No. SKIP next three questions.


Yes

Are you currently using tobacco products?

No
Yes

Yes. Amount: ______________. Are you interested in quitting? No

Have you tried to quit smoking or using tobacco products during the past
year?

No

Yes. If yes, did you stop smoking?
Yes. Date:_____________
No

Have you quit smoking or using tobacco products more than one year ago?

No

Yes. Month:________ Year:___________

In the past year:
How often did you have a drink containing alcohol?

Never
Monthly or less
week
4-5 times a week 6+ days a week

2-4 times a month 2-3 times a

How many drinks containing alcohol did you have on a typical day when
you were drinking?
1 or 2
3 or 4
5 or 6
7 to 9
10 or more
Not applicable

How often did you have six or more drinks on one occasion?

Never

Less than monthly Monthly
Daily or almost daily

Weekly

Have you enrolled in a substance abuse treatment program at the VA or in
a local community?

No
Yes.
Date(s):____________. Type(s) of
treatment:____________________
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Please check if you have used any of the following substances:
Pre-military
During military
Post-military



Marijuana



Synthetic cannabis (spice, K2, etc.)



MDMA (ectasy, X, E, XTC)



Cocaine



Methamphetamine



Heroin



LSD/hallucinogens



Medication, not as prescribed



Other:_______________________

MENTAL HEALTH
Please check any of the following mental health concerns you’ve experienced:
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SAFETY
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122
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SESSION 1
SESSION:____________

ID #: __________

Please Circle YES, NO, NOT SURE if the topic was explained today:
Was general idea of this therapy explained?
YES

NO

NOT SURE

Was the concept of dropping the shovel covered?
YES

NO

NOT SURE

Was the goal of therapy (VITALITY) discussed?
YES

NO

NOT SURE

Were the 3 parts of the triangle discussed (being present, willingness, doing what matters)?
YES

NO

NOT SURE
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SESSION:____________

ID #: __________

Please Circle YES, NO, NOT SURE if the topic was explained today:
Was a mindfulness exercise introduced?
YES

NO

NOT SURE

Were Values discussed?
YES

NO

NOT SURE

Was a shovel metaphor introduced?
YES

NO

NOT SURE
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SESSION 3
SESSION:____________

ID #: __________

Please Circle YES, NO, NOT SURE if the topic was explained today:
Was a mindfulness exercise introduced?
YES

NO

NOT SURE

Was difficulty in controlling emotions covered?
YES

NO

NOT SURE

Was an example of controlling thoughts or emotions provided?
YES

NO

NOT SURE

Did we discuss why people try to control emotions?
YES

NO

NOT SURE
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SESSION 4
SESSION:____________

ID #: __________

Please Circle YES, NO, NOT SURE if the topic was explained today:
Was a mindfulness exercise practiced?
YES

NO

NOT SURE

Was an area of values discussed?
YES

NO

NOT SURE

Was willingness discussed?
YES

NO

NOT SURE

Was an exercise for willingness (finger trap) introduced?
YES

NO

NOT SURE
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SESSION 5
SESSION:____________

ID #: __________

Please Circle YES, NO, NOT SURE if the topic was explained today:
Was a mindfulness exercise practiced?
YES

NO

NOT SURE

Was an area of values discussed?
YES

NO

NOT SURE

Was willingness reviewed?
YES

NO

NOT SURE

Was the concept of defusing from thoughts introduced?
YES

NO

NOT SURE
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SESSION 6
SESSION:____________

ID #: __________

Please Circle YES, NO, NOT SURE if the topic was explained today:
Was a mindfulness exercise practiced?
YES

NO

NOT SURE

Was an area of values discussed?
YES

NO

NOT SURE

Was defusion reviewed?
YES

NO

NOT SURE

Were exercises of defusion practiced?
YES

NO

NOT SURE
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SESSION 7
SESSION:____________

ID #: __________

Please Circle YES, NO, NOT SURE if the topic was explained today:
Was a mindfulness exercise practiced?
YES

NO

NOT SURE

Were committed actions reviewed?
YES

NO

NOT SURE

Was self- as- context discussed (chessboard)?
YES

NO

NOT SURE
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SESSION 8
SESSION:____________

ID #: __________

Please Circle YES, NO, NOT SURE if the topic was explained today:
Was a mindfulness exercise practiced?
YES

NO

NOT SURE

Were committed actions reviewed?
YES

NO

NOT SURE

Was the Passengers on the Bus Exercise practiced?
YES

NO

NOT SURE

Was the bill of rights reviewed?
YES

NO

NOT SURE
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Demographics

SESSION:____________

ID #: __________

Please answer the following questions:

1. What is your gender?

1=Female

2=Male

2. What is your marital status?

1=Single
2=Married
3=Divorced

4=Separated
5=Remarried
6=Widowed
7=other

3. What is your age? ______
4. What is your ethnicity/race?

1=African American
2=Asian American
3=Caucasian
4=Hispanic
5=Native American
6=other __________________

5. What is your current employment status?
1=Unemployed/not working
2=Working part-time
3=Working full-time (more than 30 hrs/wk)
4=On disability
5=Full-time student
6=Retired
6. What was the last grade of school you completed? What is your highest educational
degree?
1=Ph.D., M.D. (doctoral)
2=M.A./M.S. or equivalent
3=Some graduate school
4=B.A./B.S. or equivalent
5=Associates Degree
6=Some college
7=High school diploma or equivalent
8=Some high school
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7. What is your current religious identification?
1=Catholic
2=Church of Jesus Christ of Latter Day Saints
3=Protestant (Christian) specify:_______
4=Jewish
5=Islam
6=Other: specify__________
7=None
11. Have you ever sought treatment or tried other procedures before? If yes, what did you
try?
1= Medication What kind? ______________
SRI: 1=No 2= Yes
2= Cognitive Processing Therapy
3= Prolonged Exposure Therapy
4= EMDR
5= Meditation
6= Other:________
12. Are you taking any psychotropic medications or have you been on any in the past 6
months? If yes, please list with the date you started the most recent dosage.
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Appendix C
Figures
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Figure C1. Posttraumatic stress symptom scores.
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Figure C2. Well-being index and quality of life inventory.
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Figure C3. Internalized shame scale and moral injury event scale.
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Figure C4. Acceptance and action questionnaire and values questionnaire.
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Figure C5. Believability of anxious feelings and thoughts.
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SUBMITTED GRANTS
Title: A Test of Acceptance and Commitment Therapy for Marijuana Dependence &
PTSD
Date submitted: March 2012 (unfunded)
Dates: 10/12 - 09/16
Amount of Award: $1,166,880 (Direct Costs)
Funding Source: VA Clinical Science Research and Development (CSR&D)
Role: Assist with submission.
TEACHING EXPERIENCE
02/2015

Abnormal Psychology
Guest Lecturer: Eating Disorders
Utah State University

05/2012

Psychology 1010 General Psychology
Guest Lecturer: Yoga and Psychology
Utah State University

04/2012

Psychology 3050
Guest Lecturer: Randomized Controlled Trials
Utah State University

Fall 2011
Spring 2012

Graduate Teaching Assistant
PSY 1010: General Psychology, Utah State University,
Planned, taught, and managed lab sections; held regular office hours;
graded
tests and written assignments; collaborated with professor and other
teaching assistants; lectured in professors’ absence; provided
additional support for students as necessary.
Supervisors: Scott Bates, Ph.D. & Jennifer Grewe, Ph.D.
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PROFESSIONAL DEVELOPMENT TRAINING
May 2016
From Cancer to Health
Presenter: Barbara Andersen, Ph.D
Columbus, Ohio
June 2014

Relational Frame Theory in Clinical Practice
Presenters: M. Villatte, Ph.D.; Sonja Batten, Ph.D.
Minneapolis, MN

February 2014

Acceptance and Commitment Therapy Bootcamp
Presenters: Steven Hayes, Ph.D.; Kelly Wilson, Ph.D.; Kirk Stroshal,
Ph.D.
Reno, NV

September 2013 Veterans Yoga Project
Presenter: Daniel Libby Ph.D.
Feathered Pipe Foundation, Helena, MT
February 2013

Cultural Competence Training
Presenter: Michael P Twohig, Ph.D., Melanie Domenech-Rodriguez,
Ph.D.
Utah State University, Logan, UT

September 2012 Acceptance and Commitment Therapy Experiential Workshop
Presenter: Michael P Twohig, Ph.D.
Utah State University, Logan, UT
October 2013 “Mindfulness & DBT”
Presenter: Marsha Linehan, Ph.D.
FACES conferences, Seattle, WA
October 2013 “The Art & Science of Mindfulness: Integrating Mindfulness into
Psychotherapy”
Presenter: Shauna Shapiro, Ph.D.
FACES conferences, Seattle, WA
October 2013 “Mindfulness & Self Compassion”
Presenter: Kristin Neff, Ph.D.
FACES conferences, Seattle, WA
July 2012 “The Compassionate Use of Exposure Strategies in ACT”
Presenter: John Forsyth, Ph.D.
Association for Contextual Behavioral Science World Conference,
Baltimore, MD
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October 2010

Prolonged Exposure for the Treatment of PTSD (3-day training)
Presenter: Edna D. Foa, Ph.D.
Case Western Reserve University, Cleveland, OH

HONORS AND AWARDS
2015

Dissertation Fellowship Award ($5,000), Utah State University,
School of Graduate Studies

2013

Walter Borg Research Scholarship ($3,200), Utah State University,
Department of Psychology

2011 – 2014

Krantz Research Award ($420), Utah State University, Department of
Psychology

2011 – 2014

Graduate Student Senate Travel Award ($300), Utah State University

2004 – 2008

Presidential Scholarship University of Vermont

PROFESSIONAL ASSOCIATIONS
Association for Contextual Behavioral Science (ACBS), Student Member
Association for Behavioral and Cognitive Therapies (ABCT), Student Member
American Psychological Association (APA) – Division 12, Student Member
Society for Behavioral Medicine (SBM), Student Member

